Processing 00000000.tx.1: The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression* (Received for publication, January 25,1996, and in revised form, October 25,1996) Edward Korzus , Hideaki Nagase , Russell Rydell and James Travis ** From the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602,the Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas 66160,and Athena Neurosciences, Inc., SouthSanFrancisco,California94080 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES Acknowledgment REFERENCES ABSTRACT Both astrocytes in the central nervous system and fibroblasts in somatic tissues are not only the major sources of extracellular matrix components but also of matrix metalloproteinases (MMPs), a family of enzymes directly involved in extracellular matrix breakdown. 

Phrase: "The Mitogen-activated Protein Kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "JAK-STAT Signaling Pathways"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   879   C0037080:Signal Pathways [Molecular Function]
   791   C0037083:Signaling [Cell Function]
           signaling pathway
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C0086982:Signaling Pathway [Molecular Function]
   791   C1150611:JAK [Molecular Function]
   791   C1704259:Pathways [Molecular Function]
   791   C1705162:Transducer [Manufactured Object]
   791   C1705987:Pathways [Conceptual Entity]
   791   C1710082:Signal [Phenomenon or Process]
   791   C3537152:signaling [Biologic Function]

Phrase: "Are"

Phrase: "Required for an Oncostatin M-responsive Element-mediated Activation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   764   C1149423:oncostatin-M [Molecular Function]
   764   C1335093:ONCOSTATIN M [Gene or Genome]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205342:Responsive [Functional Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1514873:Required [Functional Concept]
   742   C1705248:Element [Conceptual Entity]
   742   C1879547:Activation [Activity]

Phrase: "of Matrix Metalloproteinase 1Gene Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "*"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 25,"

Phrase: "1996,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "October 25,"

Phrase: "1996"

Phrase: ")"

Phrase: "Edward Korzus ,"

Phrase: "Hideaki Nagase ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001057:NAGase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3538752:NAGASE [Laboratory Procedure]

Phrase: "Russell Rydell"

Phrase: "and"

Phrase: "James Travis"

Phrase: "*"

Phrase: "*"

Phrase: "From the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "University of Georgia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0017452:Georgia [Geographic Area]
   827   C0017454:Georgia [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   755 E C0337804:georgian [Population Group]

Phrase: "Athens,"

Phrase: "Georgia 30602,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0017452:Georgia [Geographic Area]
   861   C0017454:Georgia [Geographic Area]
   789 E C0337804:georgian [Population Group]

Phrase: "the Department of Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "University of Kansas Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0022497:Kansas [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Kansas City,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008848:City [Geographic Area]
   861   C0022497:Kansas [Geographic Area]
   861   C3262831:City [Clinical Attribute]

Phrase: "Kansas 66160,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022497:Kansas [Geographic Area]

Phrase: "and"

Phrase: "Athena Neurosciences,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   827 E C1552241:Neuroscience [Professional or Occupational Group]
   827 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "Inc.,"

Phrase: "SouthSanFrancisco,"

Phrase: "California94080 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES Acknowledgment"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "Both astrocytes in the central nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "fibroblasts in somatic tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "are"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the major sources of extracellular matrix components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449416:sources [Finding]
   714 E C1705919:Source [Idea or Concept]

Phrase: "but"

Phrase: "also of matrix metalloproteinases (MMPs),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]

Phrase: "a family of enzymes directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "involved in extracellular matrix breakdown."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0015350:Extracellular Matrix [Tissue]
   760   C0443161:break down [Qualitative Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C0699900:breakdown [Organism Function]
   760   C1265875:breakdown [Acquired Abnormality]
   760   C1314939:Involved [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
Processing 00000000.tx.2: We have analyzed the regulation of the expression of MMPs and TIMPs (tissue inhibitors of metalloproteinases) in human primary astrocytes stimulated with oncostatin M (OSM) and other extracellular mediators in comparison with normal human dermal fibroblasts. 

Phrase: "We"

Phrase: "have"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the regulation of the expression of MMPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "TIMPs"

Phrase: "(tissue inhibitors of metalloproteinases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   991   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   991   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "in human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "stimulated with oncostatin M (OSM)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "other extracellular mediators in comparison"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with normal human dermal fibroblasts."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   847   C0558145:Normal skin [Finding]
   816   C1272578:Skin fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]
   812   C0086418:Human [Human]
   812   C0205307:Normal [Qualitative Concept]
   812   C0221928:Dermal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C1522447:Dermal [Functional Concept]
   812   C2347086:% Normal [Quantitative Concept]
   756 E C0444099:Skin [Body Substance]
   756 E C1123023:Skin [Body System]
   756 E C1278993:Skin [Body System]
   729 E C0221912:Cutaneous [Spatial Concept]
Processing 00000000.tx.3: It was found that OSM induced/enhanced transcription of MMP-1 (interstitial collagenase) and MMP-3 (stromelysin 1) in astrocytes, and MMP-1, MMP-9 (gelatinase B), and TIMP-1 in fibroblasts. 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "/enhanced transcription of MMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "(interstitial collagenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0127082:Interstitial Collagenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:COLLAGENASE, INTERSTITIAL [Gene or Genome]
  1000   C2698023:Interstitial Collagenase [Laboratory Procedure]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "MMP-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "(stromelysin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:Stromelysin 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Stromelysin
  1000   C1619831:Stromelysin 1 [Laboratory Procedure]

Phrase: ")"

Phrase: "in astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "MMP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "(gelatinase B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:Gelatinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:GELATINASE B [Gene or Genome]
  1000   C2698028:Gelatinase B [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "TIMP-1 in fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.4: Analysis of the signal transduction leading to activation of the MMP-1 gene revealed the presence of an OSM-responsive element (OMRE) encompassing the AP-1 binding site and the signal transducer and activator of transcription (STAT) binding element, which mediate activation by OSM. 

Phrase: "Analysis of the signal transduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "leading to activation of the MMP-1 gene"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   800   C1417199:MMP1 gene [Gene or Genome]
           MMP1
   770   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2698023:MMP1 [Laboratory Procedure]
   767   C0017255:Gene Activation [Genetic Function]
   767   C0919336:MMP gene [Gene or Genome]
           MMP
   744   C0017337:Gene [Gene or Genome]
   744   C0332152:Leading [Temporal Concept]
   744   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1522538:Leading [Functional Concept]
   744   C1879547:Activation [Activity]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of an OSM-responsive element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(OMRE"

Phrase: ")"

Phrase: "encompassing"

Phrase: "the AP-1 binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the signal transducer and activator of transcription (STAT) binding element,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   791   C0013879:Element [Element, Ion, or Isotope]
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C0243122:binding [Functional Concept]
   791   C1145667:Binding [Activity]
   791   C1167622:Binding [Molecular Function]
   791   C1705162:Transducer [Manufactured Object]
   791   C1705248:Element [Conceptual Entity]
   791   C1710082:Signal [Phenomenon or Process]

Phrase: "which"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "activation by OSM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.5: OMRE is also present in the TIMP-1 gene promoter and, although there are some differences in these two motifs, both appear to be targets for the simultaneous action of OSM-induced nuclear effectors. 

Phrase: "OMRE"

Phrase: "is"

Phrase: "also"

Phrase: "present in the TIMP-1 gene promoter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0314621:Promoter gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: ","

Phrase: "although"

Phrase: "there"

Phrase: "are"

Phrase: "some differences in these two motifs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "both"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "targets for the simultaneous action of OSM-induced nuclear effectors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1521840:Target [Functional Concept]
   704   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.6: The induced enhancement of transcription by synergistically acting AP-1 and STAT binding elements in response to OSM is Raf-dependent. 

Phrase: "The induced enhancement of transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "by synergistically"

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "STAT binding elements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0040661:Transducer [Medical Device]
   793   C1705162:Transducer [Manufactured Object]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "Raf-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.7: Cross-talk between the mitogen-activated protein kinase and JAK-STAT pathways is required to achieve maximal induction of the OMRE-driven transcription by OSM. 

Phrase: "Cross-talk between the mitogen-activated protein kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0010357:Crosstalk [Molecular Function]
   770   C2986468:Cross-talk [Cell Function]
   744   C0037817:Talk [Organism Function]
   744   C0234856:talk [Daily or Recreational Activity]
   744   C0600118:talk [Finding]
   744   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "JAK-STAT pathways"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   878   C0037080:Signal Pathways [Molecular Function]
   793   C0040649:Transcription [Genetic Function]
   793   C0040661:Transducer [Medical Device]
   793   C1150611:JAK [Molecular Function]
   793   C1704259:Pathways [Molecular Function]
   793   C1705162:Transducer [Manufactured Object]
   793   C1705987:Pathways [Conceptual Entity]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "maximal induction of the OMRE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "transcription by OSM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.8: INTRODUCTION Astrocytes and fibroblasts each produce a complex mixture of extracellular matrix components (1), turnover of which is an integral part of many physiological processes such as development, cell migration, angiogenesis, tumor invasion (2), and neurodegenerative diseases (3, 4). 

Phrase: "INTRODUCTION Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "each"

Phrase: "produce"

Phrase: "a complex mixture of extracellular matrix components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C3641150:Mixture Component [Substance]
   748   C0439962:Mixture [Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "turnover of which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031227:turnover [Quantitative Concept]
   790   C0243127:turnover [Functional Concept]
   790   C0443331:Turnover [Health Care Activity]

Phrase: "is"

Phrase: "an integral part of many physiological processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "such as development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "cell migration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "tumor invasion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1269955:Tumor invasion [Finding]
           Invasion
   861   C2699153:Invasion [Pathologic Function]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.9: The transcriptional regulation of matrix metalloproteinases (MMPs)1 has been observed in these processes (5, 6), and after extracellular activation the activity of these enzymes can be controlled by specific TIMPs (5, 7, 8). 

Phrase: "The transcriptional regulation of matrix metalloproteinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1158770:Transcriptional Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "(MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "has"

Phrase: "been"

Phrase: "observed in these processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441672:Observed [Functional Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "and after extracellular activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0521119:Extracellular [Cell Component]
   770   C1515981:And [Idea or Concept]
   770   C1879547:Activation [Activity]

Phrase: "the activity of these enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0243102:enzyme activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "controlled by specific TIMPs"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.10: The expression of MMPs is greatly modulated by cytokines and growth factors (reviewed in Refs. 6, 7, 8), which induce cellular responses by activating intracellular signaling cascades including MAP kinase (9, 10) or JAK-STAT (11) pathways via specific cell surface receptors. 

Phrase: "The expression of MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "greatly"

Phrase: "modulated by cytokines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0443264:Modulated [Spatial Concept]
   790   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "reviewed in Refs. 6,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cellular responses by activating intracellular signaling cascades"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MAP kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0024779:Map [Manufactured Object]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1706473:Map [Conceptual Entity]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: "or"

Phrase: "JAK-STAT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0040649:Transcription [Genetic Function]
   795   C0040661:Transducer [Medical Device]
   795   C1150611:JAK [Molecular Function]
   795   C1705162:Transducer [Manufactured Object]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "(11"

Phrase: ")"

Phrase: "pathways via specific cell surface receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.11: Activated MAP kinases enter a nucleus and activate (or inactivate) transcription factors by phosphorylation of serine or threonine residues. 

Phrase: "Activated MAP kinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0024779:Map [Manufactured Object]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706473:Map [Conceptual Entity]

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "a nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "("

Phrase: "or"

Phrase: "inactivate"

Phrase: ")"

Phrase: "transcription factors by phosphorylation of serine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0040649:Transcription [Genetic Function]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "threonine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.12: Genetic and biochemical studies have revealed a series of MAP kinase nuclear substrates including those directly involved in MMPs transcriptional regulation such as the gene products of fos and jun oncogenes which compose the AP-1 transcription factor and ets family members (10, 12, 13, 14, 15). 

Phrase: "Genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "biochemical studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205474:Biochemical [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a series of MAP kinase nuclear substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "involved in MMPs transcriptional regulation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1158770:Transcriptional Regulation [Genetic Function]
   753   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0040649:Transcriptional [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1314939:Involved [Functional Concept]
   753   C1327622:Regulation [Biologic Function]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "such as the gene products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017337:Gene [Gene or Genome]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "of fos"

Phrase: "and"

Phrase: "jun oncogenes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:jun Oncogenes [Gene or Genome]
   861   C0029016:Oncogenes [Gene or Genome]

Phrase: "which"

Phrase: "compose"

Phrase: "the AP-1 transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "ets family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(10,"

Phrase: "12,"

Phrase: "13,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.13: The coordinated up-regulation of MMP-1 and TIMP-1 genes by growth factors, as well as by several nuclear and non-nuclear oncogenes (6, 16), can be explained by the combined actions of transcription factors operating through composite Ets/AP-1 motifs of the type first identified as ras-responsive elements in some mammalian promoters, including MMP-1 and TIMP-1 (16, 17). 

Phrase: "The"

Phrase: "coordinated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0427184:Coordinated [Finding]
  1000   C0700114:Coordinated [Functional Concept]
   966 E C1707511:Coordinate [Spatial Concept]

Phrase: "up-regulation of MMP-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041904:Up-Regulation [Cell Function,Molecular Function]
   806   C0162493:Up-Regulation [Genetic Function]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "TIMP-1 genes by growth factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C0812325:Growth Factor Gene [Gene or Genome]
   753   C0017337:Genes [Gene or Genome]

Phrase: "as well as by several nuclear"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "non-nuclear oncogenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029016:Oncogenes [Gene or Genome]

Phrase: "(6,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "can"

Phrase: "be"

Phrase: "explained by the combined actions of transcription factors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040649:Transcription [Genetic Function]
   744   C0205195:Combined [Qualitative Concept]
   744   C0441472:actions [Functional Concept]
   711 E C0336789:Combine [Manufactured Object]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]
   711 E C3266814:Action [Activity]

Phrase: "operating through composite Ets/AP-1 motifs of the type first"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0441729:Type 1 [Classification]
   754   C0812201:ETS-1 [Gene or Genome]
   738   C0205199:Composite [Qualitative Concept]
   738   C0205435:First [Quantitative Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C1279901:First [Qualitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1547335:Composite [Idea or Concept]
   704   C1514562:Motif [Amino Acid Sequence]
   704   C3242339:operate [Functional Concept]

Phrase: "identified as ras-responsive elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0034678:RAS [Gene or Genome]
   760   C0205342:Responsive [Functional Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "in some mammalian promoters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.14: Oncostatin M (OSM) is a multifunctional cytokine that affects the growth and differentiation of a variety of cell lines and is produced by activated monocytes and T lymphocytes (18, 19, 20). 

Phrase: "Oncostatin M"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "(OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "a multifunctional cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation of a variety of cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "produced by activated monocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0026473:Monocytes [Cell]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "T lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039194:T-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "(18,"

Phrase: "19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.15: Recently, OSM was demonstrated to be an immediate early gene induced by multiple cytokines through the JAK-Stat5 pathway (21). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an immediate early gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206256:Immediate-Early Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0205253:Immediate [Temporal Concept]
   827   C0205548:Immediate [Temporal Concept]
   827   C1279919:Early [Temporal Concept]

Phrase: "induced by multiple cytokines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0205263:Induced [Functional Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "through the JAK-Stat5 pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.16: This factor exerts a negative effect on the growth of some tumor cell lines and also acts as a positive growth regulator of normal fibroblasts, AIDS-related Kaposi's sarcoma and a TF-1 cell line (22, 23, 24). 

Phrase: "This factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a negative effect on the growth of some tumor cell lines"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   738   C0205160:Negative [Qualitative Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C1513916:Negative [Finding]
   738   C2348382:Effect [Qualitative Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "also"

Phrase: "acts as a positive growth regulator of normal fibroblasts,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   764   C1817513:growth regulator [Cell Function]
   762   C0018270:normal growth [Organism Function]
           'growth' NOS
   762   C0578019:Normal growth [Finding]
   742   C0016030:Fibroblasts [Cell]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0182953:REGULATOR [Medical Device]
   742   C0205307:Normal [Qualitative Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0439166:% normal [Quantitative Concept]
   742   C0439178:% Positive [Quantitative Concept]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1704734:Regulator [Medical Device]
   742   C1704735:Regulator [Conceptual Entity]
   742   C2347086:% Normal [Quantitative Concept]
   742   C2825490:Positive [Qualitative Concept]
   742   C2911660:Growth [Activity]

Phrase: "AIDS-related Kaposi's sarcoma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0276535:AIDS-related Kaposi sarcoma [Neoplastic Process]
  1000   C3539883:AIDS-related Kaposi Sarcoma [Intellectual Product]
   861   C0036220:KAPOSIS SARCOMA [Neoplastic Process]
   812   C1261473:Sarcoma [Neoplastic Process]

Phrase: "and"

Phrase: "a TF-1 cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.17: In addition, OSM induces differentiation of the M1 murine myeloid leukemia cell line (25), modulates the function of endothelial cells (26), up-regulates the expression of the TIMP-1 in human fibroblasts (27), and stimulates acute phase protein expression in hepatocytes (28). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation of the M1 murine myeloid leukemia cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1622499:Myeloid Cell Differentiation [Cell Function]
   762   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   742   C1511938:Differentiation [Clinical Attribute]
   742   C2945687:Differentiation [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the function of endothelial cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0007613:cells function [Cell Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "the expression of the TIMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "stimulates"

Phrase: "acute phase protein expression in hepatocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1171362:protein expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.18: Together with leukemia inhibitory factor, IL-6, and IL-11, OSM is a member of a family of pleiotropic cytokines that share (20, 29, 30) a common signal transducer, gp130, which is the component of a multiple subunit cell surface receptor (31). 

Phrase: "Together with leukemia inhibitory factor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
  1000   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1761537:leukemia inhibitory factor [Molecular Function]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   827   C3463820:Inhibitory [Activity]

Phrase: "IL-6,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334122:IL6 [Gene or Genome]
  1000   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "IL-11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0083031:il 11 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "a member of a family of pleiotropic cytokines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "that share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "(20,"

Phrase: "29,"

Phrase: "30"

Phrase: ")"

Phrase: "a common signal transducer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040661:Transducer [Medical Device]
   827   C1705162:Transducer [Manufactured Object]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "gp130,"

Phrase: "which"

Phrase: "is"

Phrase: "the component of a multiple subunit cell surface receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0243092:Cell component [Cell Component]
   762   C1178969:Cell Component [Cell Component]
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.19: More recently, the JAK-STAT signaling pathway has been shown to play an integral role in intracellular signaling by the cytokine receptors (32). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "the JAK-STAT signaling pathway"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   868   C0037080:Signal Pathway [Molecular Function]
   804   C0037083:signaling pathway [Cell Function]
           Signaling
   804   C0086982:Signaling Pathway [Molecular Function]
   790   C0040649:Transcription [Genetic Function]
   790   C0040661:Transducer [Medical Device]
   790   C1150611:JAK [Molecular Function]
   790   C1704259:Pathway [Molecular Function]
   790   C1705162:Transducer [Manufactured Object]
   790   C1705987:Pathway [Conceptual Entity]
   790   C1710082:Signal [Phenomenon or Process]
   790   C3537152:signaling [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an integral role in intracellular signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "by the cytokine receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206552:Receptors, Cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.20: Signal transducers and activators of transcription (STATs) are a unique family of transcription factors activated by many cytokine receptors (11). 

Phrase: "Signal transducers and activators of transcription (STATs)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0040661:Transducers [Medical Device]
   799   C1710082:Signal [Phenomenon or Process]
   766 E C1705162:Transducer [Manufactured Object]

Phrase: "are"

Phrase: "a unique family of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "activated by many cytokine receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0206552:Receptors, Cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.21: The ligand-receptor interaction brings the receptor-associated JAK kinases into apposition, enabling them to recruit a latent cytoplasmic STAT member family. 

Phrase: "The ligand-receptor interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "brings"

Phrase: "the receptor-associated JAK kinases into apposition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0597721:JAK Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1150611:JAK [Molecular Function]

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "them to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recruit"

Phrase: "a latent cytoplasmic STAT member family."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   788   C0010834:Cytoplasmic [Cell Component]
   788   C0015576:Family [Family Group]
   788   C0040649:Transcription [Genetic Function]
   788   C0040661:Transducer [Medical Device]
   788   C0205275:Latent [Qualitative Concept]
   788   C0521449:Cytoplasmic [Body Location or Region]
   788   C0680022:member [Population Group]
   788   C1704727:Family [Conceptual Entity]
   788   C1705162:Transducer [Manufactured Object]
   788   C1710082:Signal [Phenomenon or Process]
   788   C2698041:Member [Professional or Occupational Group]
   717 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.22: The SH2 domains of STAT proteins interact with sites of receptor tyrosine phosphorylation and become accessible for the activated JAKs. 

Phrase: "The SH2 domains of STAT proteins"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   756   C0282534:SH2 Domains [Amino Acid Sequence]
   754   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0040649:Transcription [Genetic Function]
   738   C0040661:Transducer [Medical Device]
   738   C1705162:Transducer [Manufactured Object]
   738   C1710082:Signal [Phenomenon or Process]
   737   C0162808:Protein Domains [Spatial Concept]
   721 E C1514562:Protein Domain [Amino Acid Sequence]
   704   C1880389:Domain [Functional Concept]
   704   C1883221:Domain [Conceptual Entity]
   704   C3541951:Domain [Intellectual Product]

Phrase: "interact with sites of receptor tyrosine phosphorylation"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   793   C1519727:Tyrosine Phosphorylation Site [Amino Acid Sequence]
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   774   C0005456:RECEPTOR SITES [Receptor]
   774   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C2945843:Site of [Qualitative Concept]
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0205145:Sites [Spatial Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1158886:Phosphorylation [Molecular Function]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "become"

Phrase: "accessible for the activated JAKs."
Processing 00000000.tx.23: Following activation by tyrosine phosphorylation, the STAT proteins form homo- or heterodimers that are nucleus translocated where they bind to specific regulatory elements in target genes (reviewed in Refs. 11 and 33). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "activation by tyrosine phosphorylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "the STAT proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0040649:Transcription [Genetic Function]
   793   C0040661:Transducer [Medical Device]
   793   C1705162:Transducer [Manufactured Object]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300203:Homo [Mammal]
  1000   C3245470:HOMO [Finding]

Phrase: "or"

Phrase: "heterodimers"

Phrase: "that"

Phrase: "are"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "translocated"

Phrase: "where"

Phrase: "they"

Phrase: "bind to specific regulatory elements"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   773   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0205369:Specific [Qualitative Concept]
   760   C0220905:regulatory [Regulation or Law]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1552740:specific [Intellectual Product]
   760   C1704735:Regulatory [Conceptual Entity]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "in target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1332838:Target Gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "("

Phrase: "reviewed in Refs. 11"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: "and"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.24: Although astrocytes appear to perform a function in the central nervous system similar to that of fibroblasts in somatic tissue, only limited information is available about the regulation of MMP expression in these cells (54, 74). 

Phrase: "Although"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "a function in the central nervous system"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0683212:central nervous system function [Organ or Tissue Function]
   804   C0027767:Nervous system function [Organ or Tissue Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   738   C1180473:Functional system [Body System]
   713   C0700630:neural function [Physiologic Function]

Phrase: "similar to that of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in somatic tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "only limited information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "available about the regulation of MMP expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0470187:Available [Functional Concept]
           Availability of

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(54,"

Phrase: "74"

Phrase: ")."
Processing 00000000.tx.25: Analysis of the expression of MMPs and TIMPs in human primary astrocytes stimulated with OSM and other extracellular mediators in comparison to human fibroblasts were, therefore, performed in order to determine whether this cytokine modulates MMP gene expression in these cell lines. 

Phrase: "Analysis of the expression of MMPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "TIMPs in human primary astrocytes"

Phrase: "stimulated with OSM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "other extracellular mediators in comparison to human fibroblasts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   711 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: ","

Phrase: "therefore,"

Phrase: "performed in order to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0884358:Performed [Functional Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "determine"

Phrase: "whether"

Phrase: "this cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "MMP gene expression in these cell lines."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0017262:Gene Expression [Genetic Function]
   778   C0919336:MMP gene [Gene or Genome]
   774   C1861886:CELL Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.26: The mechanisms by which OSM activates transcription of MMP-1 (interstitial collagenase) were analyzed, and an OSM-responsive element (OMRE) in which the AP-1 binding site and the SBE element cooperate together to achieve maximal inducibility by OSM has been characterized. 

Phrase: "The mechanisms by which OSM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transcription of MMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "(interstitial collagenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0127082:Interstitial Collagenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:COLLAGENASE, INTERSTITIAL [Gene or Genome]
  1000   C2698023:Interstitial Collagenase [Laboratory Procedure]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: ","

Phrase: "and"

Phrase: "an OSM-responsive element"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0205342:Responsive [Functional Concept]
   812   C1705248:Element [Conceptual Entity]
   741 E C2371924:Responsivity [Mental Process]

Phrase: "(OMRE"

Phrase: ")"

Phrase: "in which"

Phrase: "the AP-1 binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the SBE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "cooperate"

Phrase: "together to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883357:Together [Qualitative Concept]

Phrase: "achieve"

Phrase: "maximal inducibility by OSM"

Phrase: "has"

Phrase: "been"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.27: EXPERIMENTAL PROCEDURES Materials Human recombinant OSM and human recombinant IL-6 were generously donated by Immunex Comp., Seattle, WA. 

Phrase: "EXPERIMENTAL PROCEDURES Materials Human recombinant OSM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   852   C1702221:oncostatin M, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0069535:Recombinant Oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           oncostatin M
   818   C1149423:oncostatin-M [Molecular Function]
   818   C1335093:ONCOSTATIN M [Gene or Genome]
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "human recombinant IL-6"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1334122:IL6 [Gene or Genome]
   861   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0020898:IL [Geographic Area]
   812   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0022271:IL [Geographic Area]

Phrase: "were"

Phrase: "generously"

Phrase: "donated by Immunex Comp.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0056167:COMP [Therapeutic or Preventive Procedure]
   770   C0331836:Immunex [Health Care Related Organization]
   770   C1456376:COMP [Gene or Genome]

Phrase: "Seattle,"

Phrase: "WA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:WA [Geographic Area]
Processing 00000000.tx.28: Human recombinant interferon and PMA were purchased from Calbiochem, La Jolla, CA. 

Phrase: "Human recombinant interferon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1522537:Recombinant Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1514798:recombinant [Organism]

Phrase: "and"

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Calbiochem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA."
Processing 00000000.tx.29: Polyclonal anti-Jak1, anti-Jak2, and anti-Tyk2 antibodies were purchased from Upstate Biotechnology, Inc. 

Phrase: "Polyclonal anti-Jak1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0169658:JAK1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1334290:JAK1 [Gene or Genome]

Phrase: "anti-Jak2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0169661:JAK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334291:JAK2 [Gene or Genome]

Phrase: "and"

Phrase: "anti-Tyk2 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Upstate Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.30: (Lake Placid, NY). 

Phrase: "(Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: Rabbit polyclonal anti-Stat1 and anti-Stat3 antibodies were from Santa Cruz Biotechnology, Inc. 

Phrase: "Rabbit polyclonal anti-Stat1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1335872:STAT1 [Gene or Genome]
   812   C1366394:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1432814:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "anti-Stat3 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."
Processing 00000000.tx.32: (Santa Cruz, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.33: Anti-phosphotyrosine monoclonal antibodies were from Transduction Laboratories. 

Phrase: "Anti-phosphotyrosine monoclonal antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0746619:monoclonal [Finding]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Transduction Laboratories."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.34: Human cDNA MMP-3 and TIMP-1 probes were prepared by polymerase chain reaction. 

Phrase: "Human cDNA MMP-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1 probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "prepared by polymerase chain reaction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.35: Human MMP-1, MMP-2, MMP-9, and TIMP-2 cDNA probes were supplied by Dr. 

Phrase: "Human MMP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1417199:MMP1 [Gene or Genome]
   901   C2698023:MMP1 [Laboratory Procedure]
   827   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919336:MMP [Gene or Genome]

Phrase: "MMP-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MMP2 [Gene or Genome]
  1000   C2698024:MMP2 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-2 cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "supplied by Dr."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Supplied [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.36: B.L.Marner (Washington University Medical Center). 

Phrase: "B.L.Marner"

Phrase: "(Washington University Medical Center"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0043038:Washington [Geographic Area]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.37: A cDNA probe for human TIMP-3 was a gift from Dr. 

Phrase: "A cDNA probe for human TIMP-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.38: S.Apte (Harvard Medical School). 

Phrase: "S."

Phrase: "Apte"

Phrase: "(Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.39: Raf mutant expression vectors, pRSV-raf-C4 and pRSV-raf-C4PM17 (Ref. 34; no. 195) were provided by Dr. 

Phrase: "Raf mutant expression vectors,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]

Phrase: "pRSV-raf-C4"

Phrase: "and"

Phrase: "pRSV-raf-C4PM17"

Phrase: "(Ref. 34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ";"

Phrase: "no. 195"

Phrase: ")"

Phrase: "were"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.40: Ulf R.Rapp (University of Wurzburg). 

Phrase: "Ulf R.Rapp"

Phrase: "(University of Wurzburg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.41: Recombinant Plasmid Constructions In order to create a pGLMP1-Prom reporter vector, the human MMP-1 promoter (12) (525/+15 fragment) was generated by polymerase chain reaction with a human genomic DNA template and inserted into pGL2-Basic vector (Promega) in BglII site. 

Phrase: "Recombinant Plasmid Constructions In order to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a pGLMP1-Prom reporter vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "the human MMP-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(12"

Phrase: ")"

Phrase: "(525/+15 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "generated by polymerase chain reaction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]
   760   C3146294:Generated [Activity]

Phrase: "with a human genomic DNA template"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0678713:DNA template [Genetic Function]
   812   C0728990:TEMPLATE [Medical Device]
   812   C1514575:Template [Conceptual Entity]
   812   C1705542:Template [Idea or Concept]

Phrase: "and"

Phrase: "inserted into pGL2-Basic vector"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441587:Inserted [Health Care Activity]
   760   C0442335:Vector [Spatial Concept]
   760   C1527178:Basic [Functional Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1866552:PGL2 [Disease or Syndrome]
   760   C3273616:PGL2 [Gene or Genome]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "(Promega"

Phrase: ")"

Phrase: "in BglII site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.42: In pGLMP1-Prom(muSBE), a substitutive mutation was introduced by employing the Deng and Nickoloff method (35), using as a mutagenic primer 5-CACCTCTGGCTTTCTAGGGCAAGGACTC-3. 

Phrase: "In pGLMP1-Prom(muSBE"

Phrase: ")"

Phrase: ","

Phrase: "a substitutive mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "introduced by employing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0557351:employing [Finding]
   756 E C0457083:Employ [Functional Concept]
   756   C1292748:introduce [Functional Concept]

Phrase: "the Deng"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "and"

Phrase: "Nickoloff method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "using as a mutagenic primer 5-CACCTCTGGCTTTCTAGGGCAAGGACTC-3."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1524063:Using [Functional Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.43: The oligonucleotides containing the wild-type OMRE of the human MMP-1 (12) and TIMP-1 (36) promoter fragments, with or without mutation in either the SBE site or AP-1 site (see Table I), were inserted as five repeats in a head-to-tail orientation in an XhoI site of pGL2-Promoter reporter vector (Promega). 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the wild-type OMRE of the human MMP-1"

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(36"

Phrase: ")"

Phrase: "promoter fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "with"

Phrase: "or without mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in either"

Phrase: "the SBE site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "AP-1 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   734   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "inserted as five repeats"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205341:repeats [Functional Concept]
   770   C0205451:Five [Quantitative Concept]
   770   C0441587:Inserted [Health Care Activity]
   770   C1705914:Repeats [Conceptual Entity]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "in a head-to-tail orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0029266:Orientation [Mental Process]
   812   C1704322:orientation [Spatial Concept]
   812   C1704972:Orientation [Spatial Concept]
   812   C3539923:Orientation [Intellectual Product]

Phrase: "in an XhoI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of pGL2-Promoter reporter vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "(Promega"

Phrase: ")."
Processing 00000000.tx.44: Orientation, copy number, and sequences were verified by DNA sequencing. 

Phrase: "Orientation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0029266:Orientation [Mental Process]
  1000   C1704322:orientation [Spatial Concept]
  1000   C1704972:Orientation [Spatial Concept]
  1000   C3539923:Orientation [Intellectual Product]

Phrase: "copy number,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1707513:Copy Number [Quantitative Concept]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C1948062:Copy [Manufactured Object]

Phrase: "and"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "verified by DNA sequencing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   770   C1711411:Verified [Functional Concept]
Processing 00000000.tx.45: Table I. 

Phrase: "Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.46: Oligonucleotides used in gel mobility shift assays  Cell Culture and Treatment Subconfluent monolayer cultures of normal human dermal fibroblasts (NHDF; Clonetics Co., San Diego, CA) were maintained in fibroblast growth medium. 

Phrase: "Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in gel mobility shift assays  Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C0007585:Cell Culture [Laboratory Procedure]
   795   C0007634:Cell [Cell]
   795   C0010453:Culture [Idea or Concept]
   795   C0220814:culture [Functional Concept]
   795   C0430400:Culture [Laboratory Procedure]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   795   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Treatment Subconfluent monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872351:monolayer [Clinical Drug]

Phrase: "cultures of normal human dermal fibroblasts"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   756   C0558145:Normal skin [Finding]
   756   C1272578:fibroblasts skin [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0016030:Fibroblasts [Cell]
   753   C0086418:Human [Human]
   753   C0205307:Normal [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0221928:Dermal [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439166:% normal [Quantitative Concept]
   753   C1522447:Dermal [Functional Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "(NHDF"

Phrase: "; Clonetics Co.,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "were"

Phrase: "maintained in fibroblast growth medium."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0016030:Fibroblast [Cell]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C0439536:Medium [Quantitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1705217:Medium [Substance]
   760   C2911660:Growth [Activity]
   760   C3244283:medium [Intellectual Product]
   726 E C0024501:Maintain [Activity]
Processing 00000000.tx.47: Experiments with NHDF cells were performed between 3-5 passages in fibroblast growth medium supplemented with 10% fetal bovine serum (FBS), unless otherwise noted. 

Phrase: "Experiments with NHDF cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed between 3-5 passages"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0884358:Performed [Functional Concept]
   726   C0439799:Passage [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in fibroblast growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0439536:Medium [Quantitative Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C1705217:Medium [Substance]
   827   C2911660:Growth [Activity]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal bovine serum (FBS),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "unless"

Phrase: "otherwise"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.48: Human normal astrocytes were cultured in minimal essential medium containing 10% FBS, 1% glucose, 1mM sodium pyruvate, for up to 4-5 passages before they were used for experiments. 

Phrase: "Human normal astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "cultured in minimal essential medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0205224:Essential [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0547040:Minimal [Qualitative Concept]
   760   C1524031:MINIMAL [Qualitative Concept]
   760   C1705217:Medium [Substance]
   760   C2945599:Minimal [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "1% glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "1mM sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   827   C0034354:pyruvate [Organic Chemical]
   827   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "for"

Phrase: "up to 4-5 passages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439799:Passage [Spatial Concept]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: "before"

Phrase: "they"

Phrase: "were"

Phrase: "used for experiments."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.49: Transient Transfection Plasmid DNA (3g of total DNA) was transferred to exponentially growing cells in Dulbecco's modified Eagle's medium supplemented with 10% FBS on six-well tissue culture plates using the calcium phosphate-mediated transfection protocol (75). 

Phrase: "Transient Transfection Plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(3g of total DNA)"

Phrase: "was"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to exponentially growing cells in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "on six-well tissue culture plates"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   840   C0040284:Tissue culture [Laboratory Procedure]
   840   C0180454:culture plates [Medical Device]
   804   C0010453:Culture [Idea or Concept]
   804   C0040300:Tissue [Tissue]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1139930:plates [Medical Device]
   804   C1547928:Tissue [Intellectual Product]
   804   C2242979:Culture [Laboratory Procedure]
   771 E C0005971:Plate [Medical Device]
   771 E C3537155:Plate [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the calcium phosphate-mediated transfection protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0442711:Protocol [Intellectual Product]
   804   C1507394:Protocol [Intellectual Product]
   804   C1522729:Protocol [Intellectual Product]
   804   C2348563:Protocol [Intellectual Product]

Phrase: "(75"

Phrase: ")."
Processing 00000000.tx.50: The cells were harvested and assayed for luciferase activity according to the Promega protocol. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "assayed for luciferase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "according to the Promega protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.51: Transfection efficiency was assessed by cotransfection of a -galactosidase expression plasmid pSV--Gal (Promega Corp., Madison, WI); 

Phrase: "Transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "was"

Phrase: "assessed by cotransfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]

Phrase: "of a -galactosidase expression plasmid pSV--Gal (Promega Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0683758:Corp. [Organization]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.52: luciferase activity was normalized to -galactosidase activity. 

Phrase: "luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "to -galactosidase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150051:galactosidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.53: Each transfection was performed in duplicate and repeated three times using multiple DNA preparations. 

Phrase: "Each transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed in duplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "repeated three times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "multiple DNA preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.54: Yield of transfection was determined by in situ -galactosidase assays (37) and ranged from 2to 4% or from 25to 35%, in NHDF or human astrocytes, respectively. 

Phrase: "Yield of transfection"

Phrase: "was"

Phrase: "determined by in situ -galactosidase assays"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444498:In situ [Spatial Concept]
   753   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "ranged from 2to 4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "or from 25to 35%,"

Phrase: "in NHDF"

Phrase: "or"

Phrase: "human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "respectively."
Processing 00000000.tx.55: Analysis of Primary Response Gene Expression Total cellular RNA was extracted from cells by the guanidinium thiocyanate method of Chomczynski et al. 

Phrase: "Analysis of Primary Response Gene Expression Total cellular RNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   762   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "extracted from cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3282337:Cells [Cell]
   790   C3541890:EXTRACTED [Finding]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2828366:Extract [Substance]

Phrase: "by the guanidinium thiocyanate method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   734   C0061947:guanidinium thiocyanate [Organic Chemical,Pharmacologic Substance]

Phrase: "of Chomczynski et al."
Processing 00000000.tx.56: (38). 

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.57: Northern blots were made as described previously (39) and analyzed in a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "Northern blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:northern blots [Molecular Biology Research Technique]
  1000   C1621557:Northern Blots [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(39"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed in a PhosphorImager"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.58: Gel Shift and Antibody Supershift Assay Whole cellular extracts (5g of total protein) were used for EMSA, which was performed as described previously (40) with 1ng of 32P-labeled double-stranded oligonucleotides (Table I) as probes. 

Phrase: "Gel Shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "Antibody Supershift"

Phrase: "Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "Whole cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "(5g of total protein"

Phrase: ")"

Phrase: "were"

Phrase: "used for EMSA,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0596608:EMSA [Diagnostic Procedure]
   790   C0949632:EMSA [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "with 1ng"

Phrase: "of 32P-labeled double-stranded oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table I) as probes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.59: DNA-protein complex formation was carried out in a binding buffer containing 10mM Hepes, pH 7.8,50mM KCl, 1mM EDTA, 5mM MgCl2, 10% glycerol. 

Phrase: "DNA-protein complex formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1158923:protein complex formation [Molecular Function]
   902   C1817262:DNA formation [Genetic Function]
   875   C0597295:protein formation [Molecular Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   756   C2246376:DNA-protein complex [Cell Component]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a binding buffer containing 10mM Hepes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0243122:binding [Functional Concept]
   744   C0332256:Containing [Functional Concept]
   744   C0439787:Out [Spatial Concept]
   744   C0849355:Out [Qualitative Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C2700400:Containing [Activity]

Phrase: "pH 7.8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50mM KCl,"

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "5mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10% glycerol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.60: Immunoblotting For immunoprecipitation followed by immunoblotting, precleared cell lysates in IPA buffer (150mM Tris-HCl at pH 7.4,1% Nonidet P-40, 0.25% sodium deoxycholate, 150mM NaCl, 1mM EGTA, 1mM pehnylmethylsulfonyl fluoride, 1mg/ml aprotinin, 1mg/ml leupeptin, 1mg/ml pepstatin, 1mM Na3VO4, 1mM NaF) were incubated with indicated antibodies for 2h at 4C. 

Phrase: "Immunoblotting For immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "followed by immunoblotting,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "precleared"

Phrase: "cell lysates in IPA buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(150mM Tris-HCl at pH 7.4,"

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.25% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM pehnylmethylsulfonyl fluoride,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mg/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1mg/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1mg/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1mM Na3VO4,"

Phrase: "1mM NaF)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "were"

Phrase: "incubated with indicated antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1444656:Indicated [Finding]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.61: Immunocomplexes bound to protein A-Sepharose were collected by centrifugation and washed several times in IPA buffer. 

Phrase: "Immunocomplexes"

Phrase: "bound to protein A-Sepharose"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0075172:protein A-sepharose [Carbohydrate]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0522527:Protein bound [Qualitative Concept]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed several times in IPA buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.62: Immunoprecipitated proteins were resolved by 8% SDS-PAGE (41) and transferred to nitrocellulose membranes (Schleicher &Schuell). 

Phrase: "Immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved by 8% SDS-PAGE (41"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C1514893:Resolved [Idea or Concept]
   753   C1704732:Page [Intellectual Product]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Schleicher &Schuell"

Phrase: ")."
Processing 00000000.tx.63: Immunoblots were developed by use of ECL (Amersham Corp.), according to the manufacturer's protocol. 

Phrase: "Immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "developed by use of ECL (Amersham Corp."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C0683758:Corp. [Organization]
   748   C1332684:ECL [Gene or Genome]
   748   C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.64: RESULTS OSM Modulates Matrix Metalloproteinase Gene Expression We compared matrix metalloproteinase gene expression in two "stromal" human primary cell lines, which share some common functional characteristics despite their different origin. 

Phrase: "RESULTS OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1149423:oncostatin-M [Molecular Function]
   901   C1335093:ONCOSTATIN M [Gene or Genome]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "Matrix Metalloproteinase Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1334706:Metalloproteinase Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "matrix metalloproteinase gene expression in two ""stromal"" human primary cell lines,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0017262:Gene Expression [Genetic Function]
   756   C1334706:Metalloproteinase Gene [Gene or Genome]
   754   C0314604:Human gene [Gene or Genome]
   754   C1861886:CELL Gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "some common functional characteristics despite their different origin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.65: Analysis of non-activated cells had shown the presence of MMP-1, MMP-2, MMP-3, and MMP-9 in NHDF cells, but only MMP-2 could be observed in primary astrocytes at a detectable amount. 

Phrase: "Analysis of non-activated cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "had"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the presence of MMP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "MMP-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MMP2 [Gene or Genome]
  1000   C2698024:MMP2 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "MMP-9 in NHDF cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1334523:MMP9 [Gene or Genome]
   806   C2698028:MMP9 [Laboratory Procedure]
   760   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0919336:MMP [Gene or Genome]

Phrase: "but"

Phrase: "only MMP-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1334522:MMP2 [Gene or Genome]
   901   C2698024:MMP2 [Laboratory Procedure]
   827   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919336:MMP [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "observed in primary astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004112:Astrocytes [Cell]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]

Phrase: "at a detectable amount."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.66: In both cell lines, the level of the MMP-2 expression was unchanged after treatment with different activators (Fig. 1). 

Phrase: "In both cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "the level of the MMP-2 expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0456948:Level 2 [Intellectual Product]
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "unchanged after treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]
   716   C0001758:After-Treatment [Health Care Activity]

Phrase: "with different activators"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.67: IL-1 and TNF induced MMP-1 and MMP-3 in NHDF cells after 7h (data not shown), but not MMP-9, and this effect was enhanced after 24h (Fig. 1). 

Phrase: "IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "TNF"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "MMP-3 in NHDF cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0919336:MMP [Gene or Genome]

Phrase: "after 7h"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1334523:MMP9 [Gene or Genome]
   901   C2698028:MMP9 [Laboratory Procedure]
   827   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "enhanced after 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C2349975:Enhanced [Activity]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: MMP-1 and MMP-9 expression was up-regulated by IL-1 in human astrocytes, whereas MMP-3 was not (Fig. 1). 

Phrase: "MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "MMP-9 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1334523:MMP9 [Gene or Genome]
   734   C2698028:MMP9 [Laboratory Procedure]

Phrase: "was"

Phrase: "up-regulated by IL-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]

Phrase: "in human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "whereas"

Phrase: "MMP-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "was"

Phrase: "not (Fig. 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1518422:Not [Functional Concept]

Phrase: ")."
Processing 00000000.tx.69: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.70: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.71: Northern blot analysis of MMP and TIMP expression in human primary astrocytes and NHDF cells treated with different mediators. 

Phrase: "Northern blot analysis of MMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "TIMP expression in human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with different mediators."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.72: NHDF cells and human primary astrocytes were treated with either OSM (25ng/ml), IL-1 (100units/ml), TNF (10ng/ml), dexamethasone (1M), PMA (0.5M), or fibroblast growth factor-B (10ng/ml) for 24h, and the expression of several MMPs and TIMPs was measured. 

Phrase: "NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "treated with either OSM"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C1149423:oncostatin-M [Molecular Function]
   806   C1335093:ONCOSTATIN M [Gene or Genome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(25ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "IL-1 (100units/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "TNF (10ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "dexamethasone"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0011777:Dexamethasone [Pharmacologic Substance,Steroid]
   944 E C0701252:Hexadrol [Pharmacologic Substance,Steroid]
   944 E C0701261:Decaderm [Pharmacologic Substance,Steroid]
   944 E C0740057:Decadron [Pharmacologic Substance,Steroid]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "(0.5M"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "fibroblast growth factor-B (10ng/ml) for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0439446:mL/24h [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "the expression of several MMPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "TIMPs"

Phrase: "was"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.73: Total RNA was isolated and analyzed as described in "Experimental Procedures." 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in ""Experimental Procedures."""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.74: [View Larger Version of this Image (48K GIF file)] When NHDF cells were exposed to OSM, an increased level of MMP-1 mRNA (2.5times) was observed (Fig. 1). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(48K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "When"

Phrase: "NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to OSM,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "an increased level of MMP-1 mRNA (2.5times"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0456947:Level 1 [Intellectual Product]
   762   C0456948:Level 2 [Intellectual Product]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.75: The treatment of NHDF cells with OSM for 24h in the presence of IL-1, TNF, or fibroblast growth factor resulted in enhancement of MMP-1 mRNA up to 12,24,or 9.5times, respectively, while mediators without OSM induced synthesis only 5.8,8.8,and 4times (Fig. 1). 

Phrase: "The treatment of NHDF cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "TNF,"

Phrase: "or"

Phrase: "fibroblast growth factor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0016030:Fibroblast [Cell]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "resulted in enhancement of MMP-1 mRNA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1417199:MMP1 [Gene or Genome]
   778   C2698023:MMP1 [Laboratory Procedure]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0919336:MMP [Gene or Genome]
   748   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   748   C2349975:Enhancement [Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "up to 12,"

Phrase: "24,"

Phrase: "or"

Phrase: "9.5times,"

Phrase: "respectively,"

Phrase: "while"

Phrase: "mediators without OSM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   737 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "synthesis only 5.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205171:Only [Quantitative Concept]
   812   C0220781:synthesis [Biologic Function]
   812   C1720467:Only [Intellectual Product]
   812   C1883254:Synthesis [Activity]

Phrase: "8.8,"

Phrase: "and"

Phrase: "4times"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.76: OSM alone or together with IL-1, TNF, and fibroblast growth factor transiently enhanced MMP-9 after 7h in NHDF cells (data not shown). 

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or together with IL-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]
   760   C1883357:Together [Qualitative Concept]

Phrase: "TNF,"

Phrase: "and"

Phrase: "fibroblast growth factor transiently enhanced MMP-9 after 7h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   810   C0386595:fibroblast growth factor 9 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   810   C1333540:FIBROBLAST GROWTH FACTOR 9 [Gene or Genome]
   764   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1334523:MMP9 [Gene or Genome]
   764   C2698028:MMP9 [Laboratory Procedure]
   742   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0919336:MMP [Gene or Genome]

Phrase: "in NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: In human astrocytes, MMP-3 was induced only when cells were challenged with OSM and IL-1 simultaneously (Fig. 1). 

Phrase: "In human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "MMP-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "was"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "challenged with OSM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   737   C0798503:Challenge [Clinical Attribute]
   737   C0805586:Challenge [Health Care Activity]
   737   C3274764:Challenge [Conceptual Entity]

Phrase: "and"

Phrase: "IL-1 simultaneously"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.78: The cooperation between signals induced by OSM in presence of either IL-1 or PMA resulted in 100-fold or 365-fold, respectively, stimulation of MMP-1 in human astrocytes (Fig. 1). 

Phrase: "The cooperation between signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392337:cooperation [Social Behavior]

Phrase: "induced by OSM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0205263:Induced [Functional Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "in presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of either IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]

Phrase: "or"

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "resulted in 100-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "or"

Phrase: "365-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "respectively,"

Phrase: "stimulation of MMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in human astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.79: Northern blot analysis did not detect an increase of endogenous MMP-1 mRNA in response to OSM alone in these cells, perhaps, because basal MMP-1 expression was below the level of detection (Fig. 1). 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "an increase of endogenous MMP-1 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "alone in these cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "perhaps,"

Phrase: "because"

Phrase: "basal MMP-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was below the level of detection"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0043194:WAS [Disease or Syndrome]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1421478:WAS [Gene or Genome]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.80: However, the MMP-1 promoter was responsive to OSM in NHDF cells as well as in human astrocytes (Fig. 2). 

Phrase: "However,"

Phrase: "the MMP-1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417199:MMP1 [Gene or Genome]
   734   C2698023:MMP1 [Laboratory Procedure]

Phrase: "was"

Phrase: "responsive to OSM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205342:Responsive [Functional Concept]

Phrase: "in NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as well as in human astrocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004112:Astrocytes [Cell]
   753   C0086418:Human [Human]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.83: Substitutive mutation in the SBE site of the MMP-1 promoter does not remove completely the inducibility by OSM. 

Phrase: "Substitutive mutation in the SBE site of the MMP-1 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0026882:Mutation [Genetic Function]
   738   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "the inducibility by OSM."
Processing 00000000.tx.84: NHDF cells (A) or human primary astrocytes (B) were transfected with pGLMP1-Prom or pGLMP1-Prom(muSBE) or pGLMP1-AP1-SBE(5x) as described in "Experimental Procedures." 

Phrase: "NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(A)"

Phrase: "or"

Phrase: "human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "transfected with pGLMP1-Prom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015944:PROM [Pathologic Function]
   770   C0079991:PROM [Organ or Tissue Function]
   770   C1709700:PROM [Manufactured Object]

Phrase: "or"

Phrase: "pGLMP1-Prom(muSBE"

Phrase: ")"

Phrase: "or"

Phrase: "pGLMP1-AP1-SBE(5x"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in ""Experimental Procedures."""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.85: Cells were rescued for 12h and then were untreated or treated with OSM, PMA, or both for various times. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rescued for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456695:/12h [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "treated with OSM,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "both for various times."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0238767:Both [Spatial Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1632851:Times [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.86: Shown is the 24-h activation time, which gave maximal stimulation of luciferase activity. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "the 24-h activation time,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0040223:Time [Temporal Concept]
   812   C1879547:Activation [Activity]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "which"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "maximal stimulation of luciferase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.87: A pGL2Promoter (Promega) was used as a control of transfection, and its transcriptional activity in unstimulated cells was defined as 1unit of relative luciferase activity. 

Phrase: "A pGL2Promoter (Promega)"

Phrase: "was"

Phrase: "used as a control of transfection,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   767   C1524063:Use of [Functional Concept]
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   753   C0243148:control [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "its transcriptional activity in unstimulated cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "defined as 1unit of relative luciferase activity."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1151115:luciferase activity [Molecular Function]
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0080103:Relative [Family Group]
   748   C0205177:Activity [Functional Concept]
   748   C0205345:Relative [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1547039:*Relative [Quantitative Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.88: [View Larger Version of this Image (29K GIF file)] The role of OSM in the regulation of the human endogenous matrix metalloproteinase inhibitors, TIMP-1, TIMP-2 (Fig. 1), and TIMP-3 (data not shown), was investigated. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(29K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "The role of OSM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of the human endogenous matrix metalloproteinase inhibitors,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C1513016:Matrix Metalloproteinase Inhibitors [Pharmacologic Substance]
   840   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   823   C1152589:metalloproteinase inhibitor [Molecular Function]
   804   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   804   C1704640:Matrix [Spatial Concept]
   804   C1706515:Matrix [Body Substance]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "TIMP-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "TIMP-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145946:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3178655:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "TIMP-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.89: In human astrocytes, TIMP-1 was strongly activated by IL-1 and PMA, and only weakly by OSM (Fig. 1). 

Phrase: "In human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "strongly"

Phrase: "activated by IL-1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0020898:IL [Geographic Area]
   770   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0022271:IL [Geographic Area]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "and"

Phrase: "only weakly by OSM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C1149423:oncostatin-M [Molecular Function]
   806   C1335093:ONCOSTATIN M [Gene or Genome]
   760   C0205171:Only [Quantitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1720467:Only [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.90: We did not detect any up-regulation of the other two inhibitors in these cells, apart from TIMP-3 activation by PMA. 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any up-regulation of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "other two inhibitors in these cells,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "apart from TIMP-3 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1879547:Activation [Activity]
   734   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by PMA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]
Processing 00000000.tx.91: In contrast, TIMP-1 was not induced by IL-1 or by TNF in NHDF cells, similar to results obtained with both synovial fibroblasts and endothelium (42), but was increased significantly when the cells were exposed to either OSM or PMA. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induced by IL-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0020898:IL [Geographic Area]
   770   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0022271:IL [Geographic Area]
   770   C0205263:Induced [Functional Concept]

Phrase: "or by TNF"

Phrase: "in NHDF cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "similar to results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "obtained with both synovial fibroblasts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0016030:Fibroblasts [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1550315:Synovial [Body Part, Organ, or Organ Component]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "significantly"

Phrase: "when"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to either OSM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C1149423:oncostatin-M [Molecular Function]
   806   C1335093:ONCOSTATIN M [Gene or Genome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "PMA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]
Processing 00000000.tx.92: OSM Induces Sequence-specific MMP-1 and TIMP-1 Promoter-binding Proteins In order to determine the mechanism by which transcription of MMP-1 can be regulated by OSM, we addressed the question of which regulatory element(s) in the MMP-1 gene confers responsiveness to OSM. 

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Sequence-specific MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1417199:MMP1 [Gene or Genome]
   861   C2698023:MMP1 [Laboratory Procedure]
   812   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1 Promoter-binding Proteins In order to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0145988:TIMP Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "determine"

Phrase: "the mechanism by which transcription of MMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "regulated by OSM,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the question of which regulatory element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522634:Question [Intellectual Product]

Phrase: "("

Phrase: "s) in the MMP-1 gene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1417199:MMP1 gene [Gene or Genome]
           MMP1
   790   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2698023:MMP1 [Laboratory Procedure]
   783   C0393005:S-1 [Therapeutic or Preventive Procedure]
   783   C0879262:S-1 [Organic Chemical,Pharmacologic Substance]
   783   C0919336:MMP gene [Gene or Genome]
           MMP
   753   C0017337:Gene [Gene or Genome]
   753   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   753   C2603362:S' [Clinical Attribute]

Phrase: "confers"

Phrase: "responsiveness to OSM."
Processing 00000000.tx.93: It was demonstrated that a 4-fold and 5-fold activation of the MMP-1 promoter (525/+15) by OSM in transfected NHDF cells and human astrocytes, respectively, could be attained (Fig. 2). 

Phrase: "It"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a 4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "5-fold activation of the MMP-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "(525/+15"

Phrase: ")"

Phrase: "by OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "in transfected NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "respectively,"

Phrase: "could"

Phrase: "be"

Phrase: "attained"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.94: Recently, the JAK-STAT signaling pathway has been clearly linked to OSM-mediated cell activation (32). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the JAK-STAT signaling pathway"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   868   C0037080:Signal Pathway [Molecular Function]
   804   C0037083:signaling pathway [Cell Function]
           Signaling
   804   C0086982:Signaling Pathway [Molecular Function]
   790   C0040649:Transcription [Genetic Function]
   790   C0040661:Transducer [Medical Device]
   790   C1150611:JAK [Molecular Function]
   790   C1704259:Pathway [Molecular Function]
   790   C1705162:Transducer [Manufactured Object]
   790   C1705987:Pathway [Conceptual Entity]
   790   C1710082:Signal [Phenomenon or Process]
   790   C3537152:signaling [Biologic Function]

Phrase: "has"

Phrase: "been"

Phrase: "clearly"

Phrase: "linked to OSM-mediated cell activation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C1149423:oncostatin-M [Molecular Function]
   778   C1326120:cell activation [Cell Function]
   778   C1335093:ONCOSTATIN M [Gene or Genome]
   774   C0599757:M-cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1879547:Activation [Activity]
   748   C1948049:Cell [Spatial Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.95: Our sequence analysis has revealed the presence of an element homologous to the STAT binding site (SBE) (33, 43, 44, 45) in the 5-flanking region of the human MMP-1 gene between 53 and 45. 

Phrase: "Our sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "has"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of an element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "homologous to the STAT binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1334043:Homologous [Gene or Genome]

Phrase: "(SBE) (33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014122:SBE [Disease or Syndrome]

Phrase: "43,"

Phrase: "44,"

Phrase: "45"

Phrase: ")"

Phrase: "in the 5-flanking region"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0949645:5' Flanking Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
           5' Flank
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0230171:flanking [Body Location or Region]
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the human MMP-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1417199:MMP1 gene [Gene or Genome]
   902   C0314604:Human gene [Gene or Genome]
   875   C0919336:MMP gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "between 53"

Phrase: "and"

Phrase: "45."
Processing 00000000.tx.96: It should be pointed out that the SBE is only partially responsible for OSM-mediated activation of the MMP-1 promoter, since mutation of this site did not completely remove OSM inducibility (Fig. 2). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "pointed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that"

Phrase: "the SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "is"

Phrase: "only partially responsible for OSM-mediated activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "of the MMP-1 promoter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417199:MMP1 [Gene or Genome]
   734   C2698023:MMP1 [Laboratory Procedure]

Phrase: "since"

Phrase: "mutation of this site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "OSM inducibility"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   755   C0205263:Inducible [Functional Concept]
   755   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1149423:oncostatin-M [Molecular Function]
   734   C1335093:ONCOSTATIN M [Gene or Genome]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.97: Thus, SBE appears to function in conjunction with other elements of the MMP-1 promoter, which, together with SBE, could be required in order to achieve a full responsiveness to OSM. 

Phrase: "Thus,"

Phrase: "SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function in conjunction with other elements of the MMP-1 promoter,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   756   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1417199:MMP1 [Gene or Genome]
   756   C2698023:MMP1 [Laboratory Procedure]
   738   C0013879:Elements [Element, Ion, or Isotope]
   738   C0031843:function [Physiologic Function]
   738   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0542341:Function [Functional Concept]
   738   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0700205:FUNCTION [Classification]
   738   C0919336:MMP [Gene or Genome]
   738   C1705273:Function [Intellectual Product]
   738   C2699427:Conjunction [Idea or Concept]
   704 E C1705248:Element [Conceptual Entity]

Phrase: "which,"

Phrase: "together with SBE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "could"

Phrase: "be"

Phrase: "required in order to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1514873:Required [Functional Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "achieve"

Phrase: "a full responsiveness to OSM."
Processing 00000000.tx.98: It has been demonstrated previously that the positive and negative effects of tumor promoters, oncogene products, and growth factors on MMP-1 transcription is at least in part mediated by the proximal AP-1 site (12, 13, 14, 46). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "previously"

Phrase: "that"

Phrase: "the positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative effects of tumor promoters,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205160:Negative [Qualitative Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "oncogene products,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0029005:Oncogene Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "growth factors on MMP-1 transcription"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   803   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   803   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   790   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "is at least"

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "mediated by the proximal AP-1 site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0449638:Proximal site [Spatial Concept]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205107:Proximal [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(12,"

Phrase: "13,"

Phrase: "14,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.99: We demonstrated that the multimerized wild-type AP-1-SBE element conferred a very strong responsiveness to OSM, up to 7-fold or 16-fold in NHDF cells and human astrocytes, respectively (Fig. 2). 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the multimerized wild-type AP-1-SBE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0013879:Element [Element, Ion, or Isotope]
   795   C1705248:Element [Conceptual Entity]

Phrase: "conferred"

Phrase: "a very strong responsiveness to OSM,"

Phrase: "up to 7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "or"

Phrase: "16-fold in NHDF cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "respectively"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.100: Using the probe containing both the SBE and AP-1 sites of the MMP-1 promoter and different oligonucleotides for competition, we mapped the OSM-induced pattern of DNA-binding proteins. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both the SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "and"

Phrase: "AP-1 sites of the MMP-1 promoter"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   754   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "different oligonucleotides for competition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "mapped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0024779:Map [Manufactured Object]
   966   C1706473:Map [Conceptual Entity]

Phrase: "the OSM-induced pattern of DNA-binding proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1523331:pattern binding [Molecular Function]
   745   C1317658:Protein pattern [Clinical Attribute]
   742   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.101: The most retarded bands contained SBE element-binding proteins, as these components were easily out-competed when oligonucleotides with an SBE site or SIE were present in excess during DNA-protein complex formation (Fig. 3). 

Phrase: "The most retarded bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "SBE element-binding proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "as"

Phrase: "these components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "out-competed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "when"

Phrase: "oligonucleotides with an SBE site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "SIE"

Phrase: "were"

Phrase: "present in excess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "during DNA-protein complex formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1158923:protein complex formation [Molecular Function]
   902   C1817262:DNA formation [Genetic Function]
   875   C0597295:protein formation [Molecular Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   756   C2246376:DNA-protein complex [Cell Component]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: Significantly, the OSM-induced protein binding to the SBE element was activated very early, indeed within minutes. 

Phrase: "Significantly,"

Phrase: "the OSM-induced protein binding to the SBE element"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0033618:Protein Binding [Molecular Function]
   757 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0700271:M Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "very early,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "indeed within minutes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439232:minute [Temporal Concept]
   790   C0700321:minute [Quantitative Concept]
   790   C0702093:/minute [Temporal Concept]
   790   C1282918:Minute [Quantitative Concept]
   790   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.103: On the other hand, faster migrating complexes were composed of the AP-1-binding proteins, and addition of any oligonucleotide with a typical AP-1 site resulted in their complete disappearance. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "faster"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "composed of the AP-1-binding proteins,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "addition of any oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "with a typical AP-1 site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "resulted in their complete disappearance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205197:Complete [Qualitative Concept]
   760   C0725685:COMPLEAT [Food]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.104: Increase in binding to the AP-1 site was also noted, although not as rapid as to the SBE element, and the maximal level of induction was reached in approximately 1h. 

Phrase: "Increase in binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]

Phrase: "to the AP-1 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   734   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "although"

Phrase: "not as rapid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439831:Rapid [Qualitative Concept]
   790   C1518422:Not [Functional Concept]

Phrase: "as to the SBE element,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "the maximal level of induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "reached in approximately 1h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332232:Approximately [Qualitative Concept]
   770   C1442450:1H [Temporal Concept]
   737   C2584321:Reach [Organism Function]
Processing 00000000.tx.105: The binding of transcription factors to SBE site in response to OSM was not dependent on binding to the AP-1 site (and vice versa), as was demonstrated in EMSA using as probes AP-1/SBE motifs with either AP-1 or SBE sites mutated (data not shown). 

Phrase: "The binding of transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1149367:transcription factor binding [Genetic Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to SBE site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "not dependent on binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "to the AP-1 site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   734   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "was"

Phrase: "demonstrated in EMSA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596608:EMSA [Diagnostic Procedure]
   790   C0949632:EMSA [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "AP-1/SBE motifs with either AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1514562:Motif [Amino Acid Sequence]

Phrase: "or"

Phrase: "SBE sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: Very similar results were demonstrated in parallel experiments, where a DNA fragment corresponding to 97/75 DNA sequence in the human TIMP-1 promoter was used as a probe (Fig. 3B), although some differences in binding to SBE motifs were detected. 

Phrase: "Very similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "were"

Phrase: "demonstrated"

Phrase: "in parallel experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "where a DNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "corresponding to 97/75 DNA sequence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0439073:97 [Intellectual Product]
   753   C0439082:>97 [Quantitative Concept]
   753   C1519249:Sequence [Functional Concept]

Phrase: "in the human TIMP-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "some differences in binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "to SBE motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.107: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.108: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.109: OSM induces DNA binding activity to both the MMP-1 and TIMP-1 promoters. 

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "DNA binding activity to both"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2266866:Binding Activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "the MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1 promoters."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.110: The DNA fragment of MMP-1 promoter MP1-AP1-SBE (A) or T1-AP1-SBE promoter (B) encompassing the AP-1 binding site and SBE were used as labeled with 32P and used as probes in EMSA assays. 

Phrase: "The DNA fragment of MMP-1 promoter MP1-AP1-SBE ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "A)"

Phrase: "or"

Phrase: "T1-AP1-SBE promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "encompassing"

Phrase: "the AP-1 binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "labeled with 32P"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1553631:32p [Medical Device]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "used as probes"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   790   C0182400:Probes [Medical Device]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1704681:Probe [Gene or Genome]
   756 E C1947944:Use [Intellectual Product]
   756 E C2347609:Probe [Chemical Viewed Functionally]
   756 E C3536729:Probe [Manufactured Object]

Phrase: "in EMSA assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.111: NHDF cells were treated with OSM for given periods of time, and total protein extracts were prepared as described under "Experimental Procedures." 

Phrase: "NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with OSM"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for given periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "total protein extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C2828366:Extract [Substance]
   734   C0555903:Total protein [Laboratory Procedure]
   734   C1261360:total protein [Laboratory or Test Result]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.112: In competition studies a 200-fold excess of unlabeled competitor (see Table I) was used. 

Phrase: "In competition studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0679932:competition [Social Behavior]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "a 200-fold excess of unlabeled competitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1979886:Excess [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.113: The bands corresponding to SBE or AP-1 binding complexes are marked on the right side. 

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "corresponding to SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0014122:SBE [Disease or Syndrome]

Phrase: "or"

Phrase: "AP-1 binding complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "marked on the right side."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0205090:Right side [Spatial Concept]
           Right
   760   C0441987:Side [Spatial Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.114: [View Larger Version of this Image (55K GIF file)] Activation of JAK-STAT Signaling Pathway by OSM In order to examine intracellular signaling in NHDF cells induced by OSM, we investigated the activation of an OSM receptor-associated tyrosine kinase. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(55K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Activation of JAK-STAT Signaling Pathway"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   756   C0037083:signaling pathway [Cell Function]
           Signaling
   756   C0086982:Signaling Pathway [Molecular Function]
   754   C0037080:Signal Pathway [Molecular Function]
       E   pathway signaling
   754   C0162493:Transcription Activation [Genetic Function]
   754   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0040649:Transcription [Genetic Function]
   738   C0040661:Transducer [Medical Device]
   738   C1150611:JAK [Molecular Function]
   738   C1704259:Pathway [Molecular Function]
   738   C1705162:Transducer [Manufactured Object]
   738   C1705987:Pathway [Conceptual Entity]
   738   C1710082:Signal [Phenomenon or Process]
   738   C1879547:Activation [Activity]
   738   C3537152:signaling [Biologic Function]

Phrase: "by OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "examine"

Phrase: "intracellular signaling in NHDF cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C3537152:signaling [Biologic Function]

Phrase: "induced by OSM,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0205263:Induced [Functional Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the activation of an OSM receptor-associated tyrosine kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514758:Receptor Activation [Cell Function]
   739   C1879547:Activation [Activity]
Processing 00000000.tx.115: Tyrosine phosphorylation of Jak1 and Jak2, but not Tyk1, was observed as a result of cytokine activation (Fig. 4A). 

Phrase: "Tyrosine phosphorylation of Jak1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519726:Tyrosine Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Jak2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0169661:JAK-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334291:JAK2 [Gene or Genome]

Phrase: "but"

Phrase: "not Tyk1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334352:TYK1 [Gene or Genome]
   861   C1705897:TYK1 [Gene or Genome]

Phrase: "was"

Phrase: "observed as a result of cytokine activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1511613:Cytokine Activation [Physiologic Function]
   748   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1274040:Result [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1879547:Activation [Activity]
   748   C2825142:Result [Finding]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.116: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 4. 

Phrase: "4."
Processing 00000000.tx.118: OSM induces JAK-STAT signaling pathway. 

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "JAK-STAT signaling pathway."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   879   C0037080:Signal Pathway [Molecular Function]
   807   C0037083:signaling pathway [Cell Function]
           Signaling
   807   C0086982:Signaling Pathway [Molecular Function]
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C1150611:JAK [Molecular Function]
   791   C1704259:Pathway [Molecular Function]
   791   C1705162:Transducer [Manufactured Object]
   791   C1705987:Pathway [Conceptual Entity]
   791   C1710082:Signal [Phenomenon or Process]
   791   C3537152:signaling [Biologic Function]
Processing 00000000.tx.119: A, Jak1 and Jak2 are tyrosine-phoshorylated after OSM treatment. 

Phrase: "A,"

Phrase: "Jak1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0169658:JAK1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334290:JAK1 [Gene or Genome]

Phrase: "and"

Phrase: "Jak2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0169661:JAK-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334291:JAK2 [Gene or Genome]

Phrase: "are"

Phrase: "tyrosine-phoshorylated after OSM treatment."
Processing 00000000.tx.120: Western blot analysis of activation of JAK/Tyk family kinases in NHDF cells for 12min with OSM, IL-6, or interferon , and then immunoprecipitated either with anti-Jak1 or anti-Jak2 or anti-Tyk2. 

Phrase: "Western blot analysis of activation of JAK/Tyk family kinases"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C0001282:Activation Analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705493:Western [Spatial Concept]

Phrase: "in NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "for 12min"

Phrase: "with OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "IL-6,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021760:IL6 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1334122:IL6 [Gene or Genome]
  1000   C2983957:IL-6 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "or"

Phrase: "interferon ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "either with anti-Jak1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0169658:JAK1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1334290:JAK1 [Gene or Genome]

Phrase: "or"

Phrase: "anti-Jak2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0169661:JAK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1334291:JAK2 [Gene or Genome]

Phrase: "or"

Phrase: "anti-Tyk2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1421249:TYK2 [Gene or Genome]
   861   C1706299:TYK2 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.121: Immunoprecipitates were subjected to SDS-PAGE and probed with anti-phosphotyrosine antibodies. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "probed with anti-phosphotyrosine antibodies."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.122: The filters were stripped and reprobed with different anti-JAK antibodies. 

Phrase: "The filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with different anti-JAK antibodies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C1150611:JAK [Molecular Function]
   753   C1705242:Different [Qualitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.123: B, demonstration of Stat1 and Stat3 proteins in DNA binding complexes induced by OSM. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "demonstration of Stat1"

Phrase: "and"

Phrase: "Stat3 proteins in DNA binding complexes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   820   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804 E C0812382:DNA-binding protein [Gene or Genome]
   792   C1819317:protein complex binding [Molecular Function]
   792   C2246376:DNA-protein complex [Cell Component]
   783   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   773   C0253050:Stat3 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1523872:protein complex [Cell Component]

Phrase: "induced by OSM."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0205263:Induced [Functional Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.124: 32P-Labeled MP1-(muAP1)-SBE or T1-(muAP1)-SBE or hSIE DNA fragments were used in EMSA performed with total cellular extracts from NHDF cells exposed for 12min to OSM as described under "Experimental Procedures." 

Phrase: "32P-Labeled MP1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1423612:MP1 [Gene or Genome]
   827   C1425030:MP1 [Gene or Genome]

Phrase: "(muAP1"

Phrase: ")-"

Phrase: "SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "or"

Phrase: "T1-(muAP1"

Phrase: ")-"

Phrase: "SBE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "or"

Phrase: "hSIE DNA fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "used in EMSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0596608:EMSA [Diagnostic Procedure]
   790   C0949632:EMSA [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "performed with total cellular extracts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   726   C2828366:Extract [Substance]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from NHDF cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed for 12min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332157:Exposed [Clinical Attribute]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.125: [View Larger Version of this Image (65K GIF file)] In DNA gel shift assays (Fig. 3), the activation of the SBE-binding proteins by OSM was rapid and had a rather transient characteristic. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(65K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "In DNA gel shift assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   890   C0949632:Gel Shift Assay [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C0333051:Shift [Functional Concept]
   812   C1382104:Gel [Substance]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "the activation of the SBE-binding proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C2245434:activation of protein binding [Molecular Function]
   804   C2259194:activation of binding [Molecular Function]
   757   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "by OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "a rather transient characteristic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.126: In fact, the elevated DNA binding activity to the SBE element was observed only 2min after OSM stimulation, being sustained for the next hour. 

Phrase: "In fact,"

Phrase: "the elevated DNA binding activity to the SBE element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C2266866:Binding Activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only 2min after OSM stimulation,"

Phrase: "being"

Phrase: "sustained for the next hour."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205117:next [Spatial Concept]
   760   C0332282:Next [Temporal Concept]
   760   C0439227:Hour [Temporal Concept]
   760   C0443318:Sustained [Functional Concept]
   760   C0564385:/hour [Quantitative Concept]
   760   C1883708:Next [Temporal Concept]
   726 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.127: However, after 1h of incubation of NHDF cells with OSM, we could not detect any more activated STAT proteins. 

Phrase: "However,"

Phrase: "after"

Phrase: "1h of incubation of NHDF cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1442450:1H [Temporal Concept]

Phrase: "with OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any more activated STAT proteins."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0040649:Transcription [Genetic Function]
   790   C0040661:Transducer [Medical Device]
   790   C1705162:Transducer [Manufactured Object]
   790   C1710082:Signal [Phenomenon or Process]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.128: We also observed both Stat1 and Stat3 are nucleus translocated in response to OSM in human fibroblasts (data not shown), which correlated very well with the EMSA results. 

Phrase: "We also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "both Stat1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335872:STAT1 [Gene or Genome]
  1000   C1366394:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1432814:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Stat3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0253050:STAT3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1367307:STAT3 [Gene or Genome]

Phrase: "are"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "translocated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "in human fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "very well with the EMSA results."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205170:Well [Qualitative Concept]
   753   C0442824:Very [Qualitative Concept]
   753   C0596608:EMSA [Diagnostic Procedure]
   753   C0949632:EMSA [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.129: Wagner et al. 

Phrase: "Wagner et al."
Processing 00000000.tx.130: (43) and Zhong et al. 

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: "Zhong et al."
Processing 00000000.tx.131: (47) have determined the pattern and composition of proteins binding to the sis-inducible element of the fos promoter (SIE) in DNA mobility gel shift assays using cell extracts from interferon - or IL-6-induced cells. 

Phrase: "(47"

Phrase: ")"

Phrase: "have"

Phrase: "determined"

Phrase: "the pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "composition of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0486616:Composition [Clinical Attribute]
   790   C1555710:composition [Idea or Concept]

Phrase: "binding to the sis-inducible element of the fos promoter"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0013879:Element [Element, Ion, or Isotope]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205263:Inducible [Functional Concept]
   739   C0243122:binding [Functional Concept]
   739   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1704647:Sis. [Conceptual Entity]
   739   C1705248:Element [Conceptual Entity]
   739   C1705597:SIS [Gene or Genome]

Phrase: "(SIE"

Phrase: ")"

Phrase: "in DNA mobility gel shift assays"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   888   C0949632:Mobility Shift Assays [Laboratory Procedure]
           Gel Shift Assay
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C0333051:Shift [Functional Concept]
   804   C1382104:Gel [Substance]
   804   C2347509:Shift [Phenomenon or Process]
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts from interferon -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C2828366:Extract [Substance]

Phrase: "or"

Phrase: "IL-6-induced cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.132: The composition analysis of these bands revealed that SIFA consists of a Stat3 homodimer, while SIFC contains a Stat1 homodimer and SIFB is a Stat1/Stat3 heterodimer (47). 

Phrase: "The composition analysis of these bands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that SIFA"

Phrase: "consists of a Stat3 homodimer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0253050:STAT3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C1367307:STAT3 [Gene or Genome]

Phrase: "while"

Phrase: "SIFC"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a Stat1 homodimer"

Phrase: "and"

Phrase: "SIFB"

Phrase: "is"

Phrase: "a Stat1/Stat3 heterodimer"

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.133: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 4 we show that OSM is able to induce SIFA, SIFB, and SIFC complexes in gel mobility shift assays where the SIE element (5-TTTCCCGTAAA-3) (43) was used as a probe. 

Phrase: "4"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "SIFA,"

Phrase: "SIFB,"

Phrase: "and"

Phrase: "SIFC complexes in gel mobility shift assays where"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   835   C0949632:Mobility Shift Assays [Laboratory Procedure]
           Gel Shift Assay
   827   C0596608:gel mobility shift assay [Diagnostic Procedure]
   793   C0333051:Shift [Functional Concept]
   793   C0425245:Mobility [Finding]
   793   C0449580:Mobility [Qualitative Concept]
   793   C2347509:Shift [Phenomenon or Process]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   721 E C0231435:Mobile [Functional Concept]
   721 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "the SIE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "(5-TTTCCCGTAAA-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(43"

Phrase: ")"

Phrase: "was"

Phrase: "used as a probe."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.135: We then examined OSM-induced DNA-binding proteins, testing as a probe the SBE element of the MMP-1 promoter 5-ATTTCTGGAAG-3. 

Phrase: "We then examined OSM-induced DNA-binding proteins,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   850   C0700271:M Proteins [Amino Acid, Peptide, or Protein,Immunologic Factor]
   835   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818 E C0812382:DNA-binding protein [Gene or Genome]
   812   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "testing as a"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0039593:Testing [Functional Concept]
   790   C0392366:testing [Intellectual Product]
   756 E C0022885:Test [Laboratory Procedure]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the SBE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "of the MMP-1 promoter 5-ATTTCTGGAAG-3."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1417199:MMP1 [Gene or Genome]
   827   C2698023:MMP1 [Laboratory Procedure]
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0919336:MMP [Gene or Genome]
Processing 00000000.tx.136: It appeared that the Stat1 homodimer had the highest affinity to this element although we also observed some formation of a Stat3 homodimer and, presumably, a Stat1/3 heterodimer DNA complex. 

Phrase: "It"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the Stat1 homodimer"

Phrase: "had"

Phrase: "the highest affinity to this element"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "although"

Phrase: "we also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "some formation of a Stat3 homodimer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "presumably,"

Phrase: "a Stat1/3 heterodimer DNA complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.137: In addition, we noticed a new OSM-induced DNA binding complex, which was completely supershifted with antiStat1, while anti-Stat3 antibodies failed to interact. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "noticed"

Phrase: "a new OSM-induced DNA binding complex,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C1148673:DNA Binding [Genetic Function]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0243122:binding [Functional Concept]
   795   C0439855:Complex [Qualitative Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "supershifted with antiStat1,"

Phrase: "while"

Phrase: "anti-Stat3 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact."
Processing 00000000.tx.138: This complex could contain a multimer of Stat1 with another member of the STAT family or could represent an example of cross-interaction between a STAT protein and different transcriptional factors. 

Phrase: "This complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "could"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a multimer of Stat1"

Phrase: "with another member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680022:member [Population Group]
  1000   C2698041:Member [Professional or Occupational Group]

Phrase: "of the STAT family"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   791   C0015576:Family [Family Group]
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C0332285:Of [Spatial Concept]
   791   C1704727:Family [Conceptual Entity]
   791   C1705162:Transducer [Manufactured Object]
   791   C1710082:Signal [Phenomenon or Process]
   720 E C0241888:Familial [Functional Concept]

Phrase: "or"

Phrase: "could"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an example of cross-interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707959:Example [Conceptual Entity]

Phrase: "between a STAT protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C0205103:Between [Spatial Concept]
   791   C1705162:Transducer [Manufactured Object]
   791   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "different transcriptional factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcriptional [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.139: In contrast, the SBE element of the TIMP-1 promoter 5-CATCCAGGAAG-3 preferably bound the Stat3 homodimer and, to a lesser extent, the Stat1 homodimer, but bound very little if any of the Stat1/3 heterodimer. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the SBE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "of the TIMP-1 promoter 5-CATCCAGGAAG-3 preferably"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   877   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "the Stat3 homodimer"

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "the Stat1 homodimer,"

Phrase: "but"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any of the Stat1/3 heterodimer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1335872:STAT1 [Gene or Genome]
   753   C1366394:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1432814:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1552551:Any [Qualitative Concept]
   753   C3272371:ANY [Intellectual Product]
Processing 00000000.tx.140: The transcriptional discrepancy between MMP-1 and TIMP-1 responsiveness to OSM is at least to some extent the reflection of differences in binding competence of these two SBE sites, resulting from changes in DNA sequences, but the mechanism underlying such an effect remains obscure. 

Phrase: "The transcriptional discrepancy between MMP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1290905:Discrepancy [Finding]

Phrase: "and"

Phrase: "TIMP-1 responsiveness to OSM"

Phrase: "is at least"

Phrase: "to some extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "the reflection of differences"

Phrase: "in binding competence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086035:Competence [Qualitative Concept]

Phrase: "of these two SBE sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "resulting from changes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]
   756 E C2825142:Result [Finding]

Phrase: "in DNA sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "but"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "such an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "remains"

Phrase: "obscure."
Processing 00000000.tx.141: OMRE Is the Target for Cooperative Action of STAT with AP-1 during Response to OSM We have already demonstrated that both AP-1 and SBE sites in MMP-1 and TIMP-1 promoters are receiving an OSM-induced signal (Figs. 2 and 3). 

Phrase: "OMRE"

Phrase: "Is"

Phrase: "the Target for Cooperative Action of STAT"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0040649:Transcription [Genetic Function]
   736   C0040661:Transducer [Medical Device]
   736   C0441472:Action [Functional Concept]
   736   C0679729:cooperative [Organization]
   736   C1521840:Target [Functional Concept]
   736   C1705162:Transducer [Manufactured Object]
   736   C1710082:Signal [Phenomenon or Process]
   736   C2986546:TARGET [Diagnostic Procedure]
   736   C3266814:Action [Activity]

Phrase: "with AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during Response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "We"

Phrase: "have"

Phrase: "already"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "both AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SBE sites in MMP-1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "TIMP-1 promoters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "an OSM-induced signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "(Figs. 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.142: In order to demonstrate that OMRE is a mediator of transcriptional activation in response to OSM, we constructed a luciferase reporter gene with five repeats of OMRE (from MMP-1 and TIMP-1 promoters) in head-to-tail orientation inserted pGL2-Promoter: pMP1-AP1-SBE(5x)-luc and pT1-AP1-SBE(5x)-luc. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that OMRE"

Phrase: "is"

Phrase: "a mediator of transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1363844:Mediator of Activation [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Mediator

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "a luciferase reporter gene with five repeats of OMRE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0206414:Reporter Gene [Gene or Genome]
   762   C0079429:A Gene [Gene or Genome]
   762   C1334435:Luciferase Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]

Phrase: "("

Phrase: "from MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1 promoters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in head-to-tail orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0029266:Orientation [Mental Process]
   812   C1704322:orientation [Spatial Concept]
   812   C1704972:Orientation [Spatial Concept]
   812   C3539923:Orientation [Intellectual Product]

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "pGL2-Promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "pMP1-AP1-SBE(5x"

Phrase: ")-"

Phrase: "luc"

Phrase: "and"

Phrase: "pT1-AP1-SBE(5x"

Phrase: ")-"

Phrase: "luc."
Processing 00000000.tx.143: Human astrocytes were transfected with these constructs and challenged with either OSM or PMA or both. 

Phrase: "Human astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "transfected with these constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "challenged with either OSM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C1149423:oncostatin-M [Molecular Function]
   806   C1335093:ONCOSTATIN M [Gene or Genome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   726   C0798503:Challenge [Clinical Attribute]
   726   C0805586:Challenge [Health Care Activity]
   726   C3274764:Challenge [Conceptual Entity]

Phrase: "or"

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.144: PMA was chosen, since protein kinase C was shown to be an inducer of the AP-1 site in the MMP-1 promoter (12). 

Phrase: "PMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: ","

Phrase: "since"

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an inducer of the AP-1 site"

Phrase: "in the MMP-1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417199:MMP1 [Gene or Genome]
   734   C2698023:MMP1 [Laboratory Procedure]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.145: We found that pMP1-AP1-SBE(5x)-luc and pT1-AP1-SBE(5x)-luc were maximally induced after 24h of treatment with OSM, resulting in 16-fold and 8-fold stimulation of transcription, respectively (Fig. 5). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that pMP1-AP1-SBE(5x"

Phrase: ")-"

Phrase: "luc"

Phrase: "and"

Phrase: "pT1-AP1-SBE(5x"

Phrase: ")-"

Phrase: "luc"

Phrase: "were"

Phrase: "maximally"

Phrase: "induced after 24h of treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205263:Induced [Functional Concept]
   760   C0456696:/24h [Temporal Concept]
   760   C1442770:24H [Temporal Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "resulting in 16-fold"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "8-fold stimulation of transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "respectively"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.146: Remarkably, PMA, a protein kinase C activator, failed to cooperate with OSM in the transcriptional activation of the OMRE-driven luciferase expression vector. 

Phrase: "Remarkably,"

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "a protein kinase C activator,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2247123:kinase activator [Molecular Function]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cooperate with OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "in the transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162493:Transcriptional Activation [Genetic Function]
   861   C1879547:Activation [Activity]

Phrase: "of the OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase expression vector."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.147: We do not understand the basis of this phenomenon, but it is possible that an elevated PMA-induced signaling pathway is competing out a common coactivator of transcription, as was demonstrated in case of the AP-1 and a nuclear receptor (48). 

Phrase: "We"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the basis of this phenomenon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "an elevated PMA-induced signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0037083:signaling pathway [Cell Function]
   840   C0086982:Signaling Pathway [Molecular Function]
   823 E C0037080:Signal Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "competing"

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a common coactivator of transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1336776:Transcription Coactivator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "was"

Phrase: "demonstrated in case of the AP-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "a nuclear receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.148: Next, we addressed the question as to whether cis-acting regulatory sequences within OMRE of MMP-1 and TIMP-1 promoters cooperate with each other to achieve maximal induction of transcription. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the question as to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "cis-acting regulatory sequences within OMRE of MMP-1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   773   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   742   C0162326:Sequences [Nucleotide Sequence]
   742   C0220905:regulatory [Regulation or Law]
   742   C1704735:Regulatory [Conceptual Entity]
   731   C0314642:Regulatory sequence [Nucleotide Sequence]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "TIMP-1 promoters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cooperate with each other to"

Phrase: "achieve"

Phrase: "maximal induction of transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: Mutant constructs were prepared, which had five repeats of OMRE in a head-to-tail orientation inserted into the pGL2-Promoter plasmid but were defective either in the AP-1 site or in the SBE element in a manner so that they failed to bind transcription factors (Table I, Figs. 2 (A and B) and 5). 

Phrase: "Mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "five repeats of OMRE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205341:repeats [Functional Concept]
   770   C1705914:Repeats [Conceptual Entity]
   737 E C1547730:Repeat [Temporal Concept]

Phrase: "in a head-to-tail orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0029266:Orientation [Mental Process]
   812   C1704322:orientation [Spatial Concept]
   812   C1704972:Orientation [Spatial Concept]
   812   C3539923:Orientation [Intellectual Product]

Phrase: "inserted into the pGL2-Promoter plasmid"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441587:Inserted [Health Care Activity]
   753   C1866552:PGL2 [Disease or Syndrome]
   753   C3273616:PGL2 [Gene or Genome]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "but"

Phrase: "were"

Phrase: "defective either in the AP-1 site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0332452:Defective [Functional Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "or in the SBE element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013879:Element [Element, Ion, or Isotope]
   760   C0014122:SBE [Disease or Syndrome]
   760   C1705248:Element [Conceptual Entity]

Phrase: "in a manner"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "they"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(Table I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Figs. 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.150: We showed that both cis-acting motifs in OMRE are fundamental to achieving an OSM-induced maximal rate of transcription of OMRE-driven genes (Fig. 5). 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both cis-acting motifs in OMRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1514562:Motif [Amino Acid Sequence]

Phrase: "are"

Phrase: "fundamental to achieving"

Phrase: "an OSM-induced maximal rate of transcription of OMRE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0871208:Rate [Activity]
   739   C1521828:Rate [Quantitative Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.151: When the SBE element was mutated, the responsiveness to OSM was reduced drastically, although not completely. 

Phrase: "When"

Phrase: "the SBE element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "was"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "the responsiveness to OSM"

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "drastically,"

Phrase: "although"

Phrase: "not completely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]
Processing 00000000.tx.152: The basal level of the gene expression and PMA-inducibility remained unchanged, indicating that the SBE site is not involved in PMA-mediated activation. 

Phrase: "The basal level of the gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3244092:expression level [Idea or Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "PMA-inducibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0205263:Inducible [Functional Concept]
   789   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "remained"

Phrase: "unchanged,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the SBE site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in PMA-mediated activation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1879547:Activation [Activity]
   760   C2825188:PMA [Intellectual Product]
Processing 00000000.tx.153: On the other hand, the AP-1 binding site is essential for both OSM- and PMA-activation and seems to be indispensable for the basal level of gene expression in this model. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the AP-1 binding site"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0005456:Binding Site [Receptor]
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "essential for both OSM-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "PMA-activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "indispensable for the basal level of gene expression"

Phrase: "in this model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]
Processing 00000000.tx.154: These data leave no doubt that both the AP-1 and SBE sites are necessary to confer OSM responsiveness in OMRE-driven genes, and their synergistical cooperation is crucial to accomplishing maximal rates of transcription. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "leave"

Phrase: "no"

Phrase: "doubt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870444:doubt [Mental Process]

Phrase: "that"

Phrase: "both the AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SBE sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "necessary to"

Phrase: "confer"

Phrase: "OSM responsiveness in OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "their synergistical cooperation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392337:cooperation [Social Behavior]

Phrase: "is"

Phrase: "crucial to accomplishing maximal rates of transcription."
Processing 00000000.tx.155: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.157: AP-1 cooperates with STAT to achieve maximal transcription activity of the OMRE-driven luciferase vector. 

Phrase: "AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cooperates with STAT to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040649:Transcription [Genetic Function]
   742   C0040661:Transducer [Medical Device]
   742   C1705162:Transducer [Manufactured Object]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "achieve"

Phrase: "maximal transcription activity of the OMRE-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.158: Human primary astrocytes were transfected with pGLMP1-AP1-SBE(5x), pGLMP1-AP1-(muSBE)(5x), pGLMP1-(muAP1)-SBE(5x), pGLT1-AP1-SBE(5x), pGLT1-AP1-(muSBE)(5x), or pGLMP1-(muAP1)-SBE(5x) as described under "Experimental Procedures." 

Phrase: "Human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "transfected with pGLMP1-AP1-SBE(5x"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014122:SBE [Disease or Syndrome]
   753   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "pGLMP1-AP1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(muSBE"

Phrase: ")"

Phrase: "(5x"

Phrase: ")"

Phrase: ","

Phrase: "pGLMP1-"

Phrase: "(muAP1"

Phrase: ")-"

Phrase: "SBE(5x"

Phrase: ")"

Phrase: ","

Phrase: "pGLT1-AP1-SBE(5x"

Phrase: ")"

Phrase: ","

Phrase: "pGLT1-AP1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(muSBE"

Phrase: ")"

Phrase: "(5x"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "pGLMP1-"

Phrase: "(muAP1"

Phrase: ")-"

Phrase: "SBE(5x"

Phrase: ")"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.159: Cells were rescued for 12h and then challenged with OSM, PMA, or both for next 24h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rescued for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456695:/12h [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "challenged with OSM,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   737   C0798503:Challenge [Clinical Attribute]
   737   C0805586:Challenge [Health Care Activity]
   737   C3274764:Challenge [Conceptual Entity]

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "or"

Phrase: "both for next 24h."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205117:next [Spatial Concept]
   770   C0238767:Both [Spatial Concept]
   770   C0332282:Next [Temporal Concept]
   770   C0456696:/24h [Temporal Concept]
   770   C1442770:24H [Temporal Concept]
   770   C1706086:Both [Qualitative Concept]
   770   C1883708:Next [Temporal Concept]
Processing 00000000.tx.160: Cellular extracts were prepared and the luciferase activity measured as described under "Experimental Procedures." 

Phrase: "Cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.161: [View Larger Version of this Image (28K GIF file)] OSM-induced Activation of OMRE Is Raf-dependent Since the activity of both AP-1 and STAT can be modulated by the MAP kinase pathway, we investigated whether there was a requirement for one of the members of the growth promoting signal cascade, Raf-1 (49), during OMRE activation by OSM. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(28K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] OSM-induced Activation of OMRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "Is"

Phrase: "Raf-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "Since"

Phrase: "the activity of both AP-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "STAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0040661:Transducer [Medical Device]
   799   C1705162:Transducer [Manufactured Object]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "be"

Phrase: "modulated by the MAP kinase pathway,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0024779:Map [Manufactured Object]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0443264:Modulated [Spatial Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C1706473:Map [Conceptual Entity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "there"

Phrase: "was"

Phrase: "a requirement for one of the members of the growth promoting signal cascade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1514873:Requirement [Functional Concept]

Phrase: "Raf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "(49"

Phrase: ")"

Phrase: ","

Phrase: "during OMRE activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "by OSM."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.162: Raf-1 is believed to be a central cytoplasmic signal transducer in the signaling pathway induced by many extracellular activators, but its direct effect on OSM-induced transcriptional activation has not been previously studied. 

Phrase: "Raf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a central cytoplasmic signal transducer in the signaling pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0037080:Signal Pathway [Molecular Function]
   742   C0040661:Transducer [Medical Device]
   742   C1705162:Transducer [Manufactured Object]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "induced by many extracellular activators,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induced [Functional Concept]
   760   C0521119:Extracellular [Cell Component]

Phrase: "but"

Phrase: "its direct effect on OSM-induced transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "previously"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.163: In order to check this possibility, human astrocytes were co-transfected with pMP1-OMRE(5x), with a dominant negative mutant of Raf-1, pRSV-RafC4, or pRSV-RafC4PM17 serving as a control (34), and cells were challenged with OSM. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "human astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "co-transfected with pMP1-OMRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1419147:PMP1 [Gene or Genome]

Phrase: "(5x"

Phrase: ")"

Phrase: ","

Phrase: "with a dominant negative mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "of Raf-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "pRSV-RafC4,"

Phrase: "or"

Phrase: "pRSV-RafC4PM17 serving as a control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519269:Serving [Quantitative Concept]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "challenged with OSM."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   737   C0798503:Challenge [Clinical Attribute]
   737   C0805586:Challenge [Health Care Activity]
   737   C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.164: It was demonstrated that the Raf-1 dominant negative expression vector suppressed OSM induction of the OMRE-driven luciferase expression vector, whereas pRSV-RafC4PM17 was not effective (Fig. 7), which is indicative of a Raf-1 involvement in OSM-induced signal transduction. 

Phrase: "It"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the Raf-1 dominant negative expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0442335:Vector [Spatial Concept]
   799   C1705099:Vector [Idea or Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "OSM induction of the OMRE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase expression vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "whereas"

Phrase: "pRSV-RafC4PM17"

Phrase: "was"

Phrase: "not effective"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280519:effective [Qualitative Concept]
   861   C1704419:Effective [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "indicative of a Raf-1 involvement"

Phrase: "in OSM-induced signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.165: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.166: 7. 

Phrase: "7."
Processing 00000000.tx.167: Proposed mechanism of the OSM-induced activation of the OMRE. 

Phrase: "Proposed mechanism of the OSM-induced activation of the OMRE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.168: Binding of OSM to its cell surface receptor stimulates JAK-STAT and MAP kinase signaling pathways, resulting in activation of nuclear effectors, which binds to the AP-1 and SBE sites. 

Phrase: "Binding of OSM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to its cell surface receptor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "stimulates"

Phrase: "JAK-STAT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0040649:Transcription [Genetic Function]
   795   C0040661:Transducer [Medical Device]
   795   C1150611:JAK [Molecular Function]
   795   C1705162:Transducer [Manufactured Object]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "MAP kinase signaling pathways,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0752320:MAP Kinase Signaling Pathways [Cell Function,Molecular Function]
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "resulting in activation of nuclear effectors,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0332294:Resulting in [Functional Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1879547:Activation [Activity]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "which"

Phrase: "binds to the AP-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "SBE sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.169: Cooperation between the MAPK pathway and the JAK-STAT pathway is required to achieve maximal induction of the OMRE-driven transcription by OSM. 

Phrase: "Cooperation between the MAPK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392337:cooperation [Social Behavior]

Phrase: "and"

Phrase: "the JAK-STAT pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   866   C0037080:Signal Pathway [Molecular Function]
   791   C0040649:Transcription [Genetic Function]
   791   C0040661:Transducer [Medical Device]
   791   C1150611:JAK [Molecular Function]
   791   C1704259:Pathway [Molecular Function]
   791   C1705162:Transducer [Manufactured Object]
   791   C1705987:Pathway [Conceptual Entity]
   791   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "maximal induction of the OMRE-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "transcription by OSM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.170: See details under "Discussion." 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "details under ""Discussion."""
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522508:Details [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.171: [View Larger Version of this Image (30K GIF file)] The recent demonstration of the activation of the STAT signaling pathway by the oncogene for Src raises the possibility that STAT proteins can contribute to oncogenesis by Src (50). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(30K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "The recent demonstration of the activation"

Phrase: "of the STAT signaling pathway"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   868   C0037080:Signal Pathway [Molecular Function]
   804   C0037083:signaling pathway [Cell Function]
           Signaling
   804   C0086982:Signaling Pathway [Molecular Function]
   790   C0040649:Transcription [Genetic Function]
   790   C0040661:Transducer [Medical Device]
   790   C0332285:Of [Spatial Concept]
   790   C1704259:Pathway [Molecular Function]
   790   C1705162:Transducer [Manufactured Object]
   790   C1705987:Pathway [Conceptual Entity]
   790   C1710082:Signal [Phenomenon or Process]
   790   C3537152:signaling [Biologic Function]

Phrase: "by the oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "for Src"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that STAT proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0040649:Transcription [Genetic Function]
   793   C0040661:Transducer [Medical Device]
   793   C1705162:Transducer [Manufactured Object]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "contribute to oncogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007621:Oncogenesis [Neoplastic Process]
   790   C0596263:Oncogenesis [Neoplastic Process]
   790   C1880177:Contribute [Activity]

Phrase: "by Src (50"

Phrase: ")."
Processing 00000000.tx.172: Moreover, v-src and other oncogenes were found to activate the MMP-1 promoter (16). 

Phrase: "Moreover,"

Phrase: "v-src"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0080298:V-SRC [Gene or Genome]

Phrase: "and"

Phrase: "other oncogenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogenes [Gene or Genome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the MMP-1 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1417199:MMP1 [Gene or Genome]
   734   C2698023:MMP1 [Laboratory Procedure]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.173: Src is a non-receptor tyrosine kinase, which was demonstrated to activate Raf-1 (51) and mediate regulation of a variety of transcription factors. 

Phrase: "Src"

Phrase: "is"

Phrase: "a non-receptor tyrosine kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "which"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Raf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "(51"

Phrase: ")"

Phrase: "and"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "regulation of a variety of transcription factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158770:Transcription Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.174: Overexpression of the v-src oncogene in human astrocytes induced a very high transcriptional activity of the OMRE-driven luciferase expression vector and completely diminished further OSM inducibility. 

Phrase: "Overexpression of the v-src oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "in human astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a very high transcriptional activity of the OMRE-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "further OSM inducibility."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0205263:Inducible [Functional Concept]
   741   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.175: Cotransfection of human astrocytes with the v-src expression vector, the Raf dominant negative mutant, and the OMRE-driven luciferase expression vector revealed that Raf is only in part involved in v-src OMRE element activation (Fig. 6). 

Phrase: "Cotransfection of human astrocytes"

Phrase: "with the v-src expression vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "the Raf dominant negative mutant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that Raf"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "is"

Phrase: "only in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "involved in v-src OMRE element activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0080298:V-SRC [Gene or Genome]
   774   C0042306:V element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C1314939:Involved [Functional Concept]
   748   C1705248:Element [Conceptual Entity]
   748   C1879547:Activation [Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.176: At this point the biological relevance of this observation is unclear. 

Phrase: "At this"

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "the biological relevance of this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.177: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 6. 

Phrase: "6."
Processing 00000000.tx.179: OSM-induced AP1/SBE cooperation in transcription activation of the OMRE-driven luciferase construct is Raf-dependent. 

Phrase: "OSM-induced AP1/SBE cooperation in transcription activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392337:cooperation [Social Behavior]

Phrase: "of the OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "is"

Phrase: "Raf-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425569:RAF [Gene or Genome]
  1000   C1706586:RAF [Gene or Genome]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.180: Human primary astrocytes were cotransfected with pGLMP1-AP1-SBE(5x) and pRSVRaf-C4 or pRSVRaf-C4PM17 or with an empty expression vector as described under "Experimental Procedures." 

Phrase: "Human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "cotransfected with pGLMP1-AP1-SBE(5x"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014122:SBE [Disease or Syndrome]
   753   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C3536909:AP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pRSVRaf-C4"

Phrase: "or"

Phrase: "pRSVRaf-C4PM17"

Phrase: "or with an empty expression vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.181: Cells were rescued for 8h, followed by 24h of serum deprivation, and then exposed to OSM for the next 24h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rescued for 8h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292429:8H [Temporal Concept]

Phrase: "followed by 24h of serum deprivation,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0229671:Serum [Body Substance]
   753   C0456696:/24h [Temporal Concept]
   753   C0871712:Deprivation [Qualitative Concept]
   753   C1442770:24H [Temporal Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to OSM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "for the next 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]
Processing 00000000.tx.182: Cells cotransfected with the v-src expression vector were also examined. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cotransfected with the v-src expression vector"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0080298:V-SRC [Gene or Genome]
   778   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.183: The cellular extracts were prepared and the luciferase activity was measured as described under "Experimental Procedures." 

Phrase: "The cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "the luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.184: [View Larger Version of this Image (14K GIF file)] DISCUSSION Astrocytes constitute approximately 50% of the total cell number within the central nervous system (52). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(14K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] DISCUSSION Astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "constitute"

Phrase: "approximately 50% of the total cell number"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007584:Cell Number [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0332232:Approximately [Qualitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "within the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.185: Aside from their pivotal function of elaborating extracellular matrix components in the brain, these cells play essential roles in the regulation of the extracellular environment by responding and releasing growth factors and cytokines, which are involved in maintaining homeostasis in the brain extracellular fluid (1, 53). 

Phrase: "Aside from their pivotal function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "of elaborating extracellular matrix components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "essential roles in the regulation of the extracellular environment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0035820:Roles [Social Behavior]
   708 E C1705810:Role [Conceptual Entity]

Phrase: "by responding"

Phrase: "and"

Phrase: "releasing growth factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   880   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "are"

Phrase: "involved in maintaining homeostasis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019868:Homeostasis [Biologic Function]
   770   C1314939:Involved [Functional Concept]
   737   C0024501:Maintain [Activity]

Phrase: "in the brain extracellular fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0015349:Extracellular Fluid [Body Substance]
   827   C0005889:FLUID [Body Substance]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C0521119:Extracellular [Cell Component]
   827   C1704353:Fluid [Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.186: In our experiments it was found that human primary astrocytes can express several matrix metalloproteinases: MMP-1, MMP-3, MMP-2, and MMP-9, as well as their endogenous inhibitors TIMP-1, TIMP-2, and TIMP-3, although each was apparently under cell type-specific differential regulation (Fig. 1). 

Phrase: "In our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "it"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that human primary astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "can"

Phrase: "express"

Phrase: "several matrix metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: ":"

Phrase: "MMP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MMP2 [Gene or Genome]
  1000   C2698024:MMP2 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "as well as"

Phrase: "their endogenous inhibitors TIMP-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1418824:INHIBITOR 1 [Gene or Genome]

Phrase: "TIMP-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145946:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3178655:TIMP-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "TIMP-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0210492:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1527365:TIMP-3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "although"

Phrase: "each"

Phrase: "was"

Phrase: "apparently under cell type-specific differential regulation"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0007634:Cell Type [Cell]
           Cell
   778   C0449475:cell type [Intellectual Product]
   748   C0205369:Specific [Qualitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0443199:Differential [Qualitative Concept]
   748   C0750541:apparently [Idea or Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1269647:Cell [Cell]
   748   C1327622:Regulation [Biologic Function]
   748   C1547052:*Type [Quantitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704653:Cell [Medical Device]
   748   C1705242:Differential [Qualitative Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: In unstimulated cells, the only detected mRNA of all of the examined metalloproteinases was for MMP-2 (Fig. 1). 

Phrase: "In unstimulated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the only detected mRNA of all of the examined metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was for MMP-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1334522:MMP2 [Gene or Genome]
   833   C2698024:MMP2 [Laboratory Procedure]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0919336:MMP [Gene or Genome]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.188: Another gelatinase, MMP-9, could, however, be induced after stimulation with IL-1 or PMA, as was recently demonstrated in rat astrocytes (54). 

Phrase: "Another gelatinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206528:Gelatinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "could"

Phrase: ","

Phrase: "however,"

Phrase: "be"

Phrase: "induced after stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "or"

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "as"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated in rat astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0004112:Astrocytes [Cell]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.189: IL-1 and OSM synergize to stimulate MMP-1, particularly in human primary astrocytes, where they show a nearly 90-fold induction over that found with either cytokine alone (Fig. 1). 

Phrase: "IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "synergize"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "MMP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "particularly in human primary astrocytes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004112:Astrocytes [Cell]
   760   C0086418:Human [Human]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "where"

Phrase: "they"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a nearly 90-fold induction over that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "found with either cytokine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.190: Conversely, OSM, which is not an efficient inducer of TIMP expression in human primary astrocytes, has a strong positive effect on TIMP-1 in human fibroblasts. 

Phrase: "Conversely,"

Phrase: "OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an efficient inducer of TIMP expression"

Phrase: "in human primary astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "has"

Phrase: "a strong positive effect on TIMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in human fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.191: IL-1, synergistically with OSM, does induce MMP-3 expression in human astrocytes, whereas we have not observed this effect in NHDF cells. 

Phrase: "IL-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "synergistically with OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "does"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "MMP-3 expression in human astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "this effect in NHDF cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.192: Since TIMP-1, -2,and -3are not strongly up-regulated by OSM in human primary astrocytes, a net positive proteolytic activity will be created upon exposure of these cells to IL-1 and OSM. 

Phrase: "Since"

Phrase: "TIMP-1, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and -"

Phrase: "3are"

Phrase: "not strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "up-regulated by OSM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   806   C1149423:oncostatin-M [Molecular Function]
   806   C1335093:ONCOSTATIN M [Gene or Genome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0547043:Up [Spatial Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1282911:Up [Spatial Concept]

Phrase: "in human primary astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "a net positive proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C0597304:Proteolytic [Molecular Function]
   812   C1561536:*Activity [Idea or Concept]
   812   C1947941:proteolytic [Enzyme]

Phrase: "will"

Phrase: "be"

Phrase: "created upon exposure of these cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C1706214:Created [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C3244320:create [Functional Concept]

Phrase: "to IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "OSM."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.193: However, in NHDF cells, IL-1 and OSM, together, not only induce MMP-1 but also TIMP-1. 

Phrase: "However,"

Phrase: "in NHDF cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "but"

Phrase: "also TIMP-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.194: Thus MMP regulation may be more tightly controlled in fibroblasts than in astrocytes, particularly when OSM and IL-1 work in concert with each other. 

Phrase: "Thus MMP regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "more tightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "controlled in fibroblasts"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0016030:Fibroblasts [Cell]
   790   C2587213:Controlled [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "than"

Phrase: "in astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "particularly"

Phrase: "when"

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "IL-1 work in concert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "with each other."
Processing 00000000.tx.195: There is strong evidence linking neurodegenerative diseases with an imbalanced expression of proteinases and proteinase inhibitors (3, 4, 55), and an elevated metalloendopeptidase activity has been detected in Alzheimer-affected hippocampal tissue in comparison to age-matched controls (56, 57, 58). 

Phrase: "There"

Phrase: "is"

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "neurodegenerative diseases with an imbalanced expression of proteinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   744   C0012634:Diseases [Disease or Syndrome]

Phrase: "and"

Phrase: "proteinase inhibitors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   966   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   966   C2673177:proteinase inhibitor [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an elevated metalloendopeptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150172:metalloendopeptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "detected in Alzheimer-affected hippocampal tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0040300:Tissue [Tissue]
   753   C0392760:Affected [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C1314939:Affected [Functional Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "in comparison to age-matched controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0001779:Age [Organism Attribute]
   827   C0150103:matched [Research Activity]
   827   C1708943:Matched [Qualitative Concept]
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "(56,"

Phrase: "57,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.196: Since MMPs have a broad specificity, it is not without reason to assume that up-regulation of their synthesis relative to that of controlling inhibitors by elevated level of inflammatory cytokines including OSM could allow then to play a major role in neurodegenerative diseases. 

Phrase: "Since"

Phrase: "MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "have"

Phrase: "a broad specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "not without reason to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392360:Reason [Idea or Concept]
   770   C1518422:Not [Functional Concept]

Phrase: "assume"

Phrase: "that up-regulation of their synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1157723:regulation of synthesis [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "relative to that of controlling inhibitors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "by elevated level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of inflammatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "could"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "then to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in neurodegenerative diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.197: This is consistent with the recent finding that overexpression of OSM in the central nervous system of transgenic mice was detrimental and lethal (59). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the recent finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   762   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that overexpression of OSM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "of transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "detrimental"

Phrase: "and"

Phrase: "lethal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3151529:Lethal [Finding]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.198: The data presented indicate that both of the cis-acting sequences, AP-1 and SBE, present in an OMRE not only are the targets for OSM-induced nuclear effectors but also cooperate together in transcriptional activation. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "both of the cis-acting sequences,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   822   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0238767:Both [Spatial Concept]
   753   C1504308:Cis [Eukaryote]
   753   C1706086:Both [Qualitative Concept]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719   C0079613:ACT [Therapeutic or Preventive Procedure]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SBE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "present in an OMRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "are"

Phrase: "the targets for OSM-induced nuclear effectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1521840:Target [Functional Concept]
   711   C2986546:TARGET [Diagnostic Procedure]

Phrase: "but"

Phrase: "also"

Phrase: "cooperate"

Phrase: "together in transcriptional activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0162493:Transcriptional Activation [Genetic Function]
   770   C0040649:Transcriptional [Genetic Function]
   770   C1879547:Activation [Activity]
   770   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.199: We have also found this characteristic composite AP-1/SBE motif in promoters of two distally related human genes encoding human MMP-1 and its endogenous inhibitor TIMP-1. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "this characteristic composite AP-1/SBE motif in promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514562:Motif [Amino Acid Sequence]

Phrase: "of two distally related human genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   823   C0314604:Human gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "human MMP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1417199:MMP1 [Gene or Genome]
   901   C2698023:MMP1 [Laboratory Procedure]
   827   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "its endogenous inhibitor TIMP-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1418824:INHIBITOR 1 [Gene or Genome]
   861   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.200: The requirement of AP-1 and SBE sites to confer OSM responsiveness onto the rat TIMP-1 promoter was also reported (60), but neither synergistic cooperation between AP-1 and SBE in response to the cytokine nor AP-1 activation in rat hepatocytes was noted previously. 

Phrase: "The requirement of AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "SBE sites to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "confer"

Phrase: "OSM responsiveness onto the rat TIMP-1 promoter"

Phrase: "was"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(60"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "neither synergistic cooperation between AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392337:cooperation [Social Behavior]

Phrase: "and"

Phrase: "SBE in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0014122:SBE [Disease or Syndrome]

Phrase: "to the cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "nor"

Phrase: "AP-1 activation in rat hepatocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "previously."
Processing 00000000.tx.201: Composition analysis of SBE complexes revealed involvement of Stat1 and Stat3 in OSM-elevated transcriptional activation of MMP-1 and TIMP-1 genes (Fig. 4). 

Phrase: "Composition analysis of SBE complexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "involvement of Stat1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "Stat3 in OSM-elevated transcriptional activation of MMP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0253050:STAT3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1367307:STAT3 [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-1 genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Genes [Gene or Genome]
   734   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: Because of different DNA sequences, the SBE of the MMP-1 promoter had the highest affinity to the Stat1 homodimer, while the Stat3 homodimer preferably bound to the TIMP-1 promoter, although both SBE elements could bind to a lesser extent other homo- and heterodimers of STAT family members activated by OSM (Fig. 4). 

Phrase: "Because of different DNA sequences,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "the SBE of the MMP-1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014122:SBE [Disease or Syndrome]

Phrase: "had"

Phrase: "the highest affinity to the Stat1 homodimer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "while"

Phrase: "the Stat3 homodimer preferably"

Phrase: "bound to the TIMP-1 promoter,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0145947:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1522552:TIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "although"

Phrase: "both SBE elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "could"

Phrase: "bind to a lesser extent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "other homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300203:Homo [Mammal]
  1000   C3245470:HOMO [Finding]

Phrase: "and"

Phrase: "heterodimers of STAT family members"

Phrase: "activated by OSM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C1149423:oncostatin-M [Molecular Function]
   833   C1335093:ONCOSTATIN M [Gene or Genome]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.203: Whether this could explain how the JAK-STAT signal transduction pathway can accomplish specificity remains to be established. 

Phrase: "Whether"

Phrase: "this"

Phrase: "could"

Phrase: "explain"

Phrase: "how"

Phrase: "the JAK-STAT signal transduction pathway"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   873   C0086982:Signal Transduction Pathway [Molecular Function]
   870   C0037080:Signal Pathway [Molecular Function]
   860   C0037083:Signal Transduction [Cell Function]
   788   C0040649:Transcription [Genetic Function]
   788   C0040661:Transducer [Medical Device]
   788   C1150611:JAK [Molecular Function]
   788   C1160185:transduction [Organism Function]
   788   C1704259:Pathway [Molecular Function]
   788   C1705162:Transducer [Manufactured Object]
   788   C1705987:Pathway [Conceptual Entity]
   788   C1710082:Signal [Phenomenon or Process]

Phrase: "can"

Phrase: "accomplish"

Phrase: "specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.204: Moreover, OSM induces a transcription factor that binds to the AP-1 site (Fig. 2). 

Phrase: "Moreover,"

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "binds to the AP-1 site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205145:Site [Spatial Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.205: The activity of AP-1 is the function of a large group of bZip transcriptional factors including those of the Fos and Jun families, which function as Jun-Jun or Jun-Fos dimers, forming a bimolecular DNA binding domains. 

Phrase: "The activity of AP-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "the function of a large group of bZip transcriptional factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
   722   C0598132:functional group [Chemical Viewed Functionally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those of the Fos"

Phrase: "and"

Phrase: "Jun families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "which"

Phrase: "function as Jun-Jun"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "Jun-Fos dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a bimolecular DNA binding domains."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.206: Cross-family dimerization with other members of the bZip family alters DNA binding specificity (61, 62, 63). 

Phrase: "Cross-family dimerization with other members of the bZip family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "DNA binding specificity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0037791:Specificity [Quantitative Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "(61,"

Phrase: "62,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.207: It will be interesting to further investigate the composition of OSM-induced AP-1 binding complexes and their cooperation with SBE element-binding proteins in OMRE-driven transcription machinery. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the composition of OSM-induced AP-1 binding complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0486616:Composition [Clinical Attribute]
   739   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "their cooperation with SBE element-binding proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392337:cooperation [Social Behavior]

Phrase: "in OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "transcription machinery."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.208: A clue to the mechanism by which OSM might activate transcription of OMRE-driven genes is beginning to emerge (Fig. 7). 

Phrase: "A clue to the mechanism"

Phrase: "by which OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "might"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transcription of OMRE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040649:Transcription [Genetic Function]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "is"

Phrase: "beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emerge"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.209: Clearly, OSM elicits cellular responses that cannot be limited to any single signaling cascade (JAK-STAT). 

Phrase: "Clearly,"

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "cellular responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "cannot"

Phrase: "be"

Phrase: "limited to any single signaling cascade"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C2611812:signaling cascade [Cell Function]
   753   C0037083:Signaling [Cell Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0439801:Limited [Functional Concept]
   753   C1707310:Cascade [Manufactured Object]
   753   C3537152:signaling [Biologic Function]
   753   C3542948:Limited [Intellectual Product]
   719 E C1549649:Limit [Idea or Concept]
   719 E C1710082:Signal [Phenomenon or Process]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "(JAK-STAT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0040649:Transcription [Genetic Function]
   795   C0040661:Transducer [Medical Device]
   795   C1150611:JAK [Molecular Function]
   795   C1705162:Transducer [Manufactured Object]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.210: We postulate that cells must exert active MAP kinase and JAK-STAT pathways in order to maintain full OMRE inducibility by OSM. 

Phrase: "We"

Phrase: "postulate"

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "must"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "active MAP kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0024779:Map [Manufactured Object]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "JAK-STAT pathways"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   878   C0037080:Signal Pathways [Molecular Function]
   793   C0040649:Transcription [Genetic Function]
   793   C0040661:Transducer [Medical Device]
   793   C1150611:JAK [Molecular Function]
   793   C1704259:Pathways [Molecular Function]
   793   C1705162:Transducer [Manufactured Object]
   793   C1705987:Pathways [Conceptual Entity]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "full OMRE inducibility by OSM."
Processing 00000000.tx.211: Activation and cooperation between these two signaling cascades in response to OSM is required to achieve maximal transcriptional activity of the OMRE-driven luciferase vector. 

Phrase: "Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cooperation between these two signaling cascades"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392337:cooperation [Social Behavior]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "maximal transcriptional activity of the OMRE-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.212: Raf-1 is an activator of multiple nuclear effectors, including Fos, Jun, and activating transcription factors (49, 64). 

Phrase: "Raf-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812215:Raf-1 [Gene or Genome]
  1000   C1706586:RAF-1 [Gene or Genome]
           RAF
  1000   C2746015:Raf-1 [Molecular Function]
   861   C1425569:RAF [Gene or Genome]

Phrase: "is"

Phrase: "an activator of multiple nuclear effectors,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Fos,"

Phrase: "Jun,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "activating transcription factors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1148798:Activating Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   827   C1879547:activating [Activity]
   793 E C1515877:Activate [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "(49,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.213: Moreover, phosphorylation on serine 727in Stat1 and Stat3 is required for their maximal transcriptional activity (65). 

Phrase: "Moreover,"

Phrase: "phosphorylation on serine 727in Stat1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Stat3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0253050:STAT3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1367307:STAT3 [Gene or Genome]

Phrase: "is"

Phrase: "required for their maximal transcriptional activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0040649:Transcriptional [Genetic Function]
   753   C0205177:Activity [Functional Concept]
   753   C0205289:Maximal [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0806909:Maximal [Quantitative Concept]
   753   C1514873:Required [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.214: ERK2, which is a serine/threonine kinase downstream from Raf in the MAP kinase pathway, was reported to directly convert Stat1 to its fully active form by phosphorylating serine 727(66). 

Phrase: "ERK2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150579:ERK2 [Molecular Function]

Phrase: "which"

Phrase: "is"

Phrase: "a serine/threonine kinase downstream from Raf"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Threonine Kinase
           Serine Kinase
   814   C1414387:serine/threonine kinase [Gene or Genome]
   800   C0100762:A-raf Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   732   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the MAP kinase pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "convert"

Phrase: "Stat1 to its fully active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1335872:STAT1 [Gene or Genome]
   753   C1366394:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1432814:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by phosphorylating serine 727"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.215: Recently, it was shown that Jak2 was required for growth hormone-stimulated activation of ERK2/MAPK (67). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Jak2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0169661:JAK-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334291:JAK2 [Gene or Genome]

Phrase: "was"

Phrase: "required for growth hormone-stimulated activation of ERK2/MAPK (67"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   777   C2249824:activation of growth [Organism Function]
   760   C0037663:Growth Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0169964:Growth hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   757   C1155551:MAPK activation [Molecular Function]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0019932:Hormone [Hormone]
   739   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0220844:growth [Physiologic Function]
   739   C1150579:ERK2 [Molecular Function]
   739   C1514873:Required [Functional Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1879547:Activation [Activity]
   739   C1948023:Stimulated [Natural Phenomenon or Process]
   739   C2911660:Growth [Activity]

Phrase: ")."
Processing 00000000.tx.216: This could explain how OSM induced signaling bifurcates to the ERK2/MAPK and STAT signaling pathways and converges with Stat1 and Stat3 phosphorylation by ERK/MAPK, and by activation of OMRE. 

Phrase: "This"

Phrase: "could"

Phrase: "explain"

Phrase: "how OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1149423:oncostatin-M [Molecular Function]
   901   C1335093:ONCOSTATIN M [Gene or Genome]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "bifurcates to the ERK2/MAPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205383:bifurcate [Spatial Concept]
   760   C1150579:ERK2 [Molecular Function]

Phrase: "and"

Phrase: "STAT signaling pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   892   C0037080:Signal Pathways [Molecular Function]
   793   C0040661:Transducer [Medical Device]
   793   C1705162:Transducer [Manufactured Object]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "converges with Stat1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1335872:STAT1 [Gene or Genome]
   790   C1366394:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1432814:STAT1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2700387:Converge [Activity]

Phrase: "and"

Phrase: "Stat3 phosphorylation by ERK/MAPK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and by activation of OMRE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.217: This is consistent with our observation that suppression of endogenous Raf-1 impaired OSM inducibility of the OMRE-driven luciferase vector (Fig. 6). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with our observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that suppression of endogenous Raf-1 impaired OSM inducibility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0221103:Suppression [Pathologic Function]
   739   C0301625:Suppression [Organism Function]
   739   C0439181:% suppression [Quantitative Concept]
   739   C0728721:suppression [Mental Process]

Phrase: "of the OMRE-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "luciferase vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.218: The synergistic enhancement of transcription by AP-1 and STAT proteins could be accomplished by utilizing a coactivator of transcription referred to as cointegrator (48) such as a nuclear 265kDa CREB-binding protein (68), the protein linked to transactivation by CREB, Jun/Fos, and nuclear receptors (48, 69, 70). 

Phrase: "The synergistic enhancement of transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "by AP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "STAT proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0040661:Transducer [Medical Device]
   795   C1705162:Transducer [Manufactured Object]
   795   C1710082:Signal [Phenomenon or Process]

Phrase: "could"

Phrase: "be"

Phrase: "accomplished by utilizing"

Phrase: "a coactivator of transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1336776:Transcription Coactivator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "cointegrator"

Phrase: "(48"

Phrase: ")"

Phrase: "such as a nuclear 265kDa CREB-binding protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0256079:CREB-binding protein [Amino Acid, Peptide, or Protein]
   884   C1337090:CREB-BINDING PROTEIN [Gene or Genome]
   884   C1530423:CREB-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0056695:CREB Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1149372:CREB binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "linked to transactivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040624:Transactivation [Genetic Function]
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "by CREB,"

Phrase: "Jun/Fos,"

Phrase: "and"

Phrase: "nuclear receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206588:Receptors, Nuclear [Amino Acid, Peptide, or Protein,Receptor]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(48,"

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")."
Processing 00000000.tx.219: Moreover, the binding of CREB-binding protein to CREB or AP-1 proteins is serine phosphorylation-dependent (69, 70). 

Phrase: "Moreover,"

Phrase: "the binding of CREB-binding protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0256079:CREB-binding protein [Amino Acid, Peptide, or Protein]
   833   C1337090:CREB-BINDING PROTEIN [Gene or Genome]
   833   C1530423:CREB-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to CREB"

Phrase: "or"

Phrase: "AP-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "serine phosphorylation-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "(69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")."
Processing 00000000.tx.220: The strong activation of OMRE by v-src and suppression of OMRE inducibility by dominant negative Raf-1 mutant (Fig. 6) support this hypothesis, since both Src and Raf-1 kinases trigger serine kinase activity (49, 51, 64). 

Phrase: "The strong activation of OMRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by v-src"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0080298:V-SRC [Gene or Genome]

Phrase: "and"

Phrase: "suppression of OMRE inducibility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "by dominant negative Raf-1 mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "since"

Phrase: "both Src"

Phrase: "and"

Phrase: "Raf-1 kinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   988   C0139030:raf-1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   913   C1449849:raf Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0812215:Raf-1 [Gene or Genome]
   734   C1706586:RAF-1 [Gene or Genome]
   734   C2746015:Raf-1 [Molecular Function]

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "serine kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2261503:serine kinase activity [Molecular Function]
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(49,"

Phrase: "51,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.221: Alternatively, OSM has been shown to stimulate a rapid but transient elevation of primary response genes including c-Jun (71), and products of this gene can enhance OMRE, already activated by STAT transcriptional factors, as a positive feedback regulatory loop. 

Phrase: "Alternatively,"

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "but"

Phrase: "transient elevation of primary response genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "c-Jun (71"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162508:c-Jun [Gene or Genome]
   827   C0450389:71 [Intellectual Product]
   827   C1553033:[c] [Quantitative Concept]
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "products of this gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1514468:Products [Entity]
   737 E C1704444:Product [Quantitative Concept]

Phrase: "can"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "OMRE,"

Phrase: "already"

Phrase: "activated by STAT transcriptional factors,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   757   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040649:Transcription [Genetic Function]
   739   C0040661:Transducer [Medical Device]
   739   C1705162:Transducer [Manufactured Object]
   739   C1710082:Signal [Phenomenon or Process]
   739   C1879547:Activated [Activity]
   706 E C1515877:Activate [Functional Concept]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]

Phrase: "as"

Phrase: "a positive feedback regulatory loop."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678662:regulatory loop [Physiologic Function]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
Processing 00000000.tx.222: The mechanism by which OSM activates transcription of immediate-early genes is not always clear, but most likely this induction is mediated by the JAK-STAT pathway, and the newly biosynthesized transcriptional factors could further enhance transcription of later genes such as MMPs and TIMPs. 

Phrase: "The mechanism by which OSM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "transcription of immediate-early genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0013458:Early Gene Transcription [Genetic Function]
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "is"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "this induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "mediated by the JAK-STAT pathway,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   754   C0037080:Signal Pathway [Molecular Function]
   754   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0040649:Transcription [Genetic Function]
   738   C0040661:Transducer [Medical Device]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C1150611:JAK [Molecular Function]
   738   C1704259:Pathway [Molecular Function]
   738   C1705162:Transducer [Manufactured Object]
   738   C1705987:Pathway [Conceptual Entity]
   738   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "the newly biosynthesized transcriptional factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   825   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcriptional [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "could"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "transcription of later genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C0023099:Late Gene Transcription [Genetic Function]
   819   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "such as MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "TIMPs."
Processing 00000000.tx.223: OSM is expressed by activated monocytes and T-lymphocytes (19, 20), and it may be involved in modulation of stromal cell function at inflammatory sites since fibroblasts, astrocytes, and also endothelium (26) respond very strongly to this cytokine. 

Phrase: "OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "expressed by activated monocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0026473:Monocytes [Cell]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "T-lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0039194:T-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "involved in modulation of stromal cell function"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0007613:Cell Function [Cell Function]
   778   C0162597:Stromal cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0443264:Modulation [Spatial Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1314939:Involved [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   743 E C0596291:stroma cell [Cell Component]

Phrase: "at inflammatory sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "since"

Phrase: "fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "also endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014257:Endothelium [Tissue]

Phrase: "(26"

Phrase: ")"

Phrase: "respond"

Phrase: "very strongly to this cytokine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0442824:Very [Qualitative Concept]
Processing 00000000.tx.224: The ability to bind gp130 directly as well as two other receptor subunits, leukemia inhibitory factor receptor and oncostatin M receptor (72, 73), provides OSM with a variety of activities that any other member of this cytokines family. 

Phrase: "The ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "gp130 directly"

Phrase: "as well as"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other receptor subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "leukemia inhibitory factor receptor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0125607:leukemia inhibitory factor receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1334339:LEUKEMIA INHIBITORY FACTOR RECEPTOR [Gene or Genome]
   923   C0125606:leukemia inhibitory factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1366463:LEUKEMIA-INHIBITORY FACTOR [Gene or Genome]
   923   C1453955:Leukemia-Inhibitory Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1761537:leukemia inhibitory factor [Molecular Function]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3463820:Inhibitory [Activity]

Phrase: "and"

Phrase: "oncostatin M receptor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0083861:oncostatin M receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1173441:Oncostatin M Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1335092:ONCOSTATIN M RECEPTOR [Gene or Genome]
   901   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1149423:oncostatin-M [Molecular Function]
   901   C1335093:ONCOSTATIN M [Gene or Genome]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(72,"

Phrase: "73"

Phrase: ")"

Phrase: ","

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "OSM with a variety of activities"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   778   C1149423:oncostatin-M [Molecular Function]
   778   C1335093:ONCOSTATIN M [Gene or Genome]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]

Phrase: "that"

Phrase: "any other member of this cytokines family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.225: The recent finding that a tissue-specific targeted bovine OSM in transgenic mice had a profound and often lethal effects (59) raises the possibility that OSM plays a role in the regulation of development and homeostasis. 

Phrase: "The recent finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "a tissue-specific targeted bovine OSM in transgenic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   761   C1700522:oncostatin M, mouse [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1149423:oncostatin-M [Molecular Function]
   760   C1335093:ONCOSTATIN M [Gene or Genome]
   757   C2346751:A/m [Quantitative Concept]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]

Phrase: "had"

Phrase: "a profound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439808:Profound [Qualitative Concept]

Phrase: "and"

Phrase: "often lethal effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1280500:effects [Qualitative Concept]
   827   C3151529:Lethal [Finding]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "(59"

Phrase: ")"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that OSM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the regulation of development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "homeostasis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.226: The physiological function of OSM is still unknown, and the targeted gene disruption could be the experiment of choice in order to establish the primary function of this cytokine. 

Phrase: "The physiological function of OSM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "still unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "the targeted gene disruption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332453:Disruption [Functional Concept]
   717   C1332838:Target Gene [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "the experiment of choice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the primary function of this cytokine."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.227: FOOTNOTES * This work was supported by Grants HL 37090(to J.T.) 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grants HL 37090"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0018173:Grants [Quantitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to J."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")"
Processing 00000000.tx.228: and AR39189 (to H.N.) from the National Institutes of Health. 

Phrase: "and"

Phrase: "AR39189"

Phrase: "("

Phrase: "to H.N.)"

Phrase: "from the National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.229: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.230: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.231: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.232: Present address: HHMI, University of California San Diego, Dept. of Medicine, La Jolla, CA 92093. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "HHMI,"

Phrase: "University of California San Diego,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0006754:California [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C1826357:San [Gene or Genome]
   804   C3146274:California [Plant]

Phrase: "Dept."

Phrase: "of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92093."
Processing 00000000.tx.233: ** To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.234: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.235: 706-542-1711; 

Phrase: "706-542-1711"

Phrase: ";"
Processing 00000000.tx.236: Fax: 706-542-3719. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "706-542-3719."
Processing 00000000.tx.237: 1 The abbreviations used are: MMP, matrix metalloproteinase; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "MMP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919336:MMP [Gene or Genome]

Phrase: "matrix metalloproteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: ";"
Processing 00000000.tx.238: MMP-1, interstitial collagenase; 

Phrase: "MMP-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0127082:MMP-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:MMP1 [Gene or Genome]
  1000   C2698023:MMP1 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "interstitial collagenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0127082:Interstitial Collagenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417199:COLLAGENASE, INTERSTITIAL [Gene or Genome]
  1000   C2698023:Interstitial Collagenase [Laboratory Procedure]
   861   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.239: MMP-2, gelatinase A; 

Phrase: "MMP-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MMP2 [Gene or Genome]
  1000   C2698024:MMP2 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "gelatinase A"

Phrase: ";"
Processing 00000000.tx.240: MMP-3, stromelysin-1; 

Phrase: "MMP-3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:MMP-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "stromelysin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0164371:Stromelysin 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Stromelysin
  1000   C1619831:Stromelysin 1 [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.241: MMP-9, gelatinase B; 

Phrase: "MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "gelatinase B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0165519:Gelatinase B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:GELATINASE B [Gene or Genome]
  1000   C2698028:Gelatinase B [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.242: AP-1, the transcription factor AP-1; 

Phrase: "AP-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085828:AP 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the transcription factor AP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085828:Transcription Factor AP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           AP 1
  1000   C3536909:Transcription Factor AP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.243: CREB, cAMP response element-binding protein; 

Phrase: "CREB,"

Phrase: "cAMP response element-binding protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.244: ERK/MAPK; 

Phrase: "ERK/MAPK"

Phrase: ";"
Processing 00000000.tx.245: extracellular signal-regulated kinase/mitogen-activated protein kinase; 

Phrase: "extracellular signal-regulated kinase/mitogen-activated protein kinase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   878   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   836   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
           PROTEIN KINASE
   835   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   793   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0026249:Mitogen [Pharmacologic Substance]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1879547:Activated [Activity]
   760 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.246: MAP, mitogen-activated protein; 

Phrase: "MAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "mitogen-activated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.247: OSM, oncostatin M; 

Phrase: "OSM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "oncostatin M"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0069535:oncostatin M [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
  1000   C1149423:oncostatin-M [Molecular Function]
  1000   C1335093:ONCOSTATIN M [Gene or Genome]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.248: OMRE, OSM-responsive element; 

Phrase: "OMRE,"

Phrase: "OSM-responsive element"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0205342:Responsive [Functional Concept]
   812   C1705248:Element [Conceptual Entity]
   741 E C2371924:Responsivity [Mental Process]

Phrase: ";"
Processing 00000000.tx.249: PMA, phorbol 12-myristate 13-acetate; 

Phrase: "PMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039654:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C0048451:PMA [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
  1000   C2825188:PMA [Intellectual Product]

Phrase: "phorbol 12-myristate 13-acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   717   C0767601:phorbol-12-myristate [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.250: SBE, STAT binding site; 

Phrase: "SBE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014122:SBE [Disease or Syndrome]

Phrase: "STAT binding site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   878   C0552269:Transducer site [Clinical Attribute]
   878   C0552634:Transducer site [Spatial Concept]
   793   C0040661:Transducer [Medical Device]
   793   C1705162:Transducer [Manufactured Object]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.251: SIE, sis-inducible factor response element; 

Phrase: "SIE,"

Phrase: "sis-inducible factor response element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.252: SIF, sis-inducible factor; 

Phrase: "SIF,"

Phrase: "sis-inducible factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.253: STAT, signal transducer and activator of transcription; 

Phrase: "STAT,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0040661:Transducer [Medical Device]
   799   C1705162:Transducer [Manufactured Object]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "signal transducer and activator of transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0040661:Transducer [Medical Device]
   799   C1705162:Transducer [Manufactured Object]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.254: TIMP, tissue inhibitor of metalloproteinase; 

Phrase: "TIMP,"

Phrase: "tissue inhibitor of metalloproteinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0145988:tissue inhibitor of metalloproteinase [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   819   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.255: IL, interleukin; 

Phrase: "IL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "interleukin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.256: NHDF, normal human dermal fibroblasts; 

Phrase: "NHDF,"

Phrase: "normal human dermal fibroblasts"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   847   C0558145:Normal skin [Finding]
   816   C1272578:Skin fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]
   812   C0086418:Human [Human]
   812   C0205307:Normal [Qualitative Concept]
   812   C0221928:Dermal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C1522447:Dermal [Functional Concept]
   812   C2347086:% Normal [Quantitative Concept]
   756 E C0444099:Skin [Body Substance]
   756 E C1123023:Skin [Body System]
   756 E C1278993:Skin [Body System]
   729 E C0221912:Cutaneous [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.257: FBS, fetal bovine serum; 

Phrase: "FBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.258: TNF, tumor necrosis factor; 

Phrase: "TNF,"

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.259: EMSA, electrophoretic mobility shift assay. 

Phrase: "EMSA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596608:EMSA [Diagnostic Procedure]
  1000   C0949632:EMSA [Laboratory Procedure]

Phrase: "electrophoretic mobility shift assay."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assay
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   812   C2347509:Shift [Phenomenon or Process]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.260: Acknowledgment We thank the following people and their co-workers for their generous gifts provided for these studies: Dr. 

Phrase: "Acknowledgment"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the following people"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027361:People [Population Group]

Phrase: "and"

Phrase: "their co-workers for their generous gifts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0024752:workers [Functional Concept]
   748   C1306056:workers [Occupation or Discipline]
   748   C1527116:Workers [Population Group]

Phrase: "provided for these studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   770   C1999230:Provided [Activity]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.261: Ulf R.Rapp for Raf-1 dominant negative mutant expression vector; 

Phrase: "Ulf R.Rapp for Raf-1 dominant negative mutant expression vector"

Phrase: ";"
Processing 00000000.tx.262: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.263: Tony Hunter (Salk Institute) for v-src expression vector; 

Phrase: "Tony Hunter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "(Salk Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for v-src expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.264: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.265: B.L.Marner for human MMP-1, MMP-2, MMP-9, and TIMP-2 cDNA probes; 

Phrase: "B.L.Marner for human MMP-1,"

Phrase: "MMP-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0172537:MMP-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MMP2 [Gene or Genome]
  1000   C2698024:MMP2 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "MMP-9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0165519:MMP-9 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334523:MMP9 [Gene or Genome]
  1000   C2698028:MMP9 [Laboratory Procedure]
   861   C0623362:MMP [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919336:MMP [Gene or Genome]

Phrase: "and"

Phrase: "TIMP-2 cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.266: and Dr. 

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.267: S.Apte for human TIMP-3 cDNA probe. 

Phrase: "S."

Phrase: "Apte for human TIMP-3 cDNA probe."
Processing 00000000.tx.268: REFERENCES Shnitka, T. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Shnitka,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.269: K., and Malhotra, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Malhotra,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.270: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.271: (1993) Advances in Neural Sciences, Vol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Advances in Neural Sciences,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0036397:Sciences [Occupation or Discipline]
   770   C0599851:Neural [Functional Concept]
   770   C0725066:Advance [Medical Device]
   715 E C0027740:Nerve [Tissue]
   715 E C0027757:NERVE [Tissue]
   715 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.272: 1, pp. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "pp."
Processing 00000000.tx.273: 161-186, JAI Press Inc., New York Rifkin, D. 

Phrase: "161-186,"

Phrase: "JAI Press Inc.,"

Phrase: "New York Rifkin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "D."
Processing 00000000.tx.274: B., Tsuboi, R., and Mignatti, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tsuboi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mignatti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.275: (1989) Am. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.276: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.277: Respir. 

Phrase: "Respir."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205535:RESPIR [Functional Concept]
Processing 00000000.tx.278: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.279: 140, 1112-1113 [Medline] [OrderarticleviaInfotrieve] Abraham, C. 

Phrase: "140,"

Phrase: "1112-1113"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.280: R., Selkoe, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.281: J., and Potter, H. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.282: (1988) Cell 52, 487-501 [CrossRef][Medline] [OrderarticleviaInfotrieve] Nelson, R. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Cell 52,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "487-501"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nelson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.283: B., Siman, R., Iqbal, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Iqbal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.284: A., and Potter, H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.285: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.286: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.287: 61, 567-577 [Medline] [OrderarticleviaInfotrieve] Werb, Z., Alexander, C. 

Phrase: "61,"

Phrase: "567-577"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Werb,"

Phrase: "Z.,"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "C."
Processing 00000000.tx.288: M., and Adler, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Adler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.289: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.290: (1992) in Matrix Metalloproteinases and Inhibitors (Birkedal-Hansen, H., Werb, Z., Velgus, H. G., and Van Wart, H. E., eds), pp. 

Phrase: "(1992"

Phrase: ")"

Phrase: "in Matrix Metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "Inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Birkedal-Hansen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Werb,"

Phrase: "Z.,"

Phrase: "Velgus,"

Phrase: "H. G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560020:h g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Van Wart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043037:Wart [Disease or Syndrome]
   861   C1547970:Wart [Intellectual Product]

Phrase: "H. E.,"

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.291: 337-343, Gustav Fisher, Stuttgart Birkedal-Hansen, H., Moore, W. 

Phrase: "337-343,"

Phrase: "Gustav Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325045:Fisher [Mammal]

Phrase: "Stuttgart Birkedal-Hansen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.292: G.I., Bodden, M. 

Phrase: "G.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bodden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.293: K., Windsor, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Windsor,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.294: J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. 

Phrase: "J.,"

Phrase: "Birkedal-Hansen,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "DeCarlo,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Engler,"

Phrase: "J."
Processing 00000000.tx.295: A. 

Phrase: "A."
Processing 00000000.tx.296: (1993) Crit. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Crit."
Processing 00000000.tx.297: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.298: Oral Biol. 

Phrase: "Oral Biol."
Processing 00000000.tx.299: Med. 

Phrase: "Med."
Processing 00000000.tx.300: 4, 197-250 [Abstract] Birkedal-Hansen, H. 

Phrase: "4,"

Phrase: "197-250"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Birkedal-Hansen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.301: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.302: Periodont. 

Phrase: "Periodont."
Processing 00000000.tx.303: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.304: 28, 500-510 [Medline] [OrderarticleviaInfotrieve] Mauviel, A. 

Phrase: "28,"

Phrase: "500-510"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mauviel,"

Phrase: "A."
Processing 00000000.tx.305: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.306: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.307: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.308: 53, 288-295 [Medline] [OrderarticleviaInfotrieve] Mashall, C. 

Phrase: "53,"

Phrase: "288-295"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mashall,"

Phrase: "C."
Processing 00000000.tx.309: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.310: Opin. 

Phrase: "Opin."
Processing 00000000.tx.311: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.312: Biol. 

Phrase: "Biol."
Processing 00000000.tx.313: 4, 82-89 Karin, M. 

Phrase: "4,"

Phrase: "82-89 Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.314: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.315: Opin. 

Phrase: "Opin."
Processing 00000000.tx.316: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.317: Biol. 

Phrase: "Biol."
Processing 00000000.tx.318: 6, 415-424 [Medline] [OrderarticleviaInfotrieve] Ihle, J. 

Phrase: "6,"

Phrase: "415-424"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ihle,"

Phrase: "J."
Processing 00000000.tx.319: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.320: (1996) Cell 84, 331-334 [Medline] [OrderarticleviaInfotrieve] Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 84,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "331-334"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Angel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baumann,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Delius,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rahmsdorf,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.321: J., and Herrlich, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Herrlich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.322: (1987) Mol. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.323: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.324: Biol. 

Phrase: "Biol."
Processing 00000000.tx.325: 7, 2256-2266 [Medline] [OrderarticleviaInfotrieve] Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, M. 

Phrase: "7,"

Phrase: "2256-2266"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Angel,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Imagawa,"

Phrase: "M."

Phrase: ","

Phrase: "Chiu,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stein,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Imbra,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.326: J., Rahmsdorf, H. 

Phrase: "J.,"

Phrase: "Rahmsdorf,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.327: J., Jonat, C., Herrlich, P., and Karin, M. 

Phrase: "J.,"

Phrase: "Jonat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Herrlich,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: (1987) Cell 49, 729-739 [Medline] [OrderarticleviaInfotrieve] Hunter, T., and Karin, M. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Cell 49,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "729-739"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: (1992) Cell 70, 375-387 [Medline] [OrderarticleviaInfotrieve] Hill, C. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell 70,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "375-387"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "C."
Processing 00000000.tx.330: S., and Treisman, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Treisman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.331: (1995) Cell 80, 199-211 [Medline] [OrderarticleviaInfotrieve] Gutman, A., and Wasylyk, B. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 80,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "199-211"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gutman,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Wasylyk,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.332: (1990) EMBO J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.333: 9, 2241-2246 [Abstract] Edwards, D. 

Phrase: "9,"

Phrase: "2241-2246"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Edwards,"

Phrase: "D."
Processing 00000000.tx.334: R., Rocheleau, H., Sharma, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rocheleau,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: R., Willis, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Willis,"

Phrase: "A."
Processing 00000000.tx.336: J., Cowie, A., Hassel, J. 

Phrase: "J.,"

Phrase: "Cowie,"

Phrase: "A.,"

Phrase: "Hassel,"

Phrase: "J."
Processing 00000000.tx.337: A., and Heath, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Heath,"

Phrase: "J."
Processing 00000000.tx.338: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.339: (1992) Biochim. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.340: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.341: Acta 1171, 41-55 [Medline] [OrderarticleviaInfotrieve] Brown, T. 

Phrase: "Acta 1171,"

Phrase: "41-55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.342: J., Lioubin, M. 

Phrase: "J.,"

Phrase: "Lioubin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.343: N., and Marquardt, H. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Marquardt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.344: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.345: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.346: 139, 2977-2983 [Abstract/Free FullText] Malik, N., Kallestad, J. 

Phrase: "139,"

Phrase: "2977-2983"

Phrase: "[Abstract/Free FullText"

Phrase: "] Malik,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kallestad,"

Phrase: "J."
Processing 00000000.tx.347: C., Gunderson, N. 

Phrase: "C., Gunderson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.348: L., Austin, S. 

Phrase: "L., Austin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0605411:austin [Organic Chemical]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: D., Neubauer, M. 

Phrase: "D."

Phrase: ","

Phrase: "Neubauer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.350: G., Ochs, V., Marquardt, H., Zarling, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ochs,"

Phrase: "V.,"

Phrase: "Marquardt,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zarling,"

Phrase: "J."
Processing 00000000.tx.351: M., Shoyab, M., Wei, C. 

Phrase: "M."

Phrase: ","

Phrase: "Shoyab,"

Phrase: "M."

Phrase: ","

Phrase: "Wei,"

Phrase: "C."
Processing 00000000.tx.352: M., Linsley, P. 

Phrase: "M."

Phrase: ","

Phrase: "Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.353: S., and Rose, T. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.354: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: (1989) Mol. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.356: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.357: Biol. 

Phrase: "Biol."
Processing 00000000.tx.358: 9, 2847-2853 [Medline] [OrderarticleviaInfotrieve] Bruce, A. 

Phrase: "9,"

Phrase: "2847-2853"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.359: G., Linsley, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: S., and Rose, T. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.361: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.362: (1992) Prog. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.363: Growth Factor Res. 

Phrase: "Growth Factor Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.364: 4, 157-170 [Medline] [OrderarticleviaInfotrieve] Yoshimura, A., Ichihara, M., Kinjyo, I., Moriyama, M., Copeland, N. 

Phrase: "4,"

Phrase: "157-170"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yoshimura,"

Phrase: "A.,"

Phrase: "Ichihara,"

Phrase: "M."

Phrase: ","

Phrase: "Kinjyo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Moriyama,"

Phrase: "M."

Phrase: ","

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.365: G., Gilbert, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.366: D., Jenkins, N. 

Phrase: "D."

Phrase: ","

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.367: A., Hara, T., and Miyajima, A. 

Phrase: "A.,"

Phrase: "Hara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2758676:Hara [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Miyajima,"

Phrase: "A."
Processing 00000000.tx.368: (1996) EMBO J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.369: 15, 1055-1063 [Abstract] Horn, D., Fitzpatrick, W. 

Phrase: "15,"

Phrase: "1055-1063"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Horn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "D."

Phrase: ","

Phrase: "Fitzpatrick,"

Phrase: "W."
Processing 00000000.tx.370: C., Gompper, P. 

Phrase: "C., Gompper,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.371: T., Ochs, V., Bolton-Hansen, M., Zarling, J., Malik, N., Todaro, G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ochs,"

Phrase: "V.,"

Phrase: "Bolton-Hansen,"

Phrase: "M."

Phrase: ","

Phrase: "Zarling,"

Phrase: "J.,"

Phrase: "Malik,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Todaro,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.372: J., and Linsley, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: (1990) Growth Factors 2, 157-165 [Medline] [OrderarticleviaInfotrieve] Nair, B. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Growth Factors 2,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "157-165"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nair,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: C., DeVico, A. 

Phrase: "C., DeVico,"

Phrase: "A."
Processing 00000000.tx.376: L., Nakamura, S., Copeland, T. 

Phrase: "L., Nakamura,"

Phrase: "S."

Phrase: ","

Phrase: "Copeland,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.377: D., Chen, Y., Patel, A., O'Neil, T., Oroszlan, S., Gallo, R. 

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Y.,"

Phrase: "Patel,"

Phrase: "A.,"

Phrase: "O'Neil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Oroszlan,"

Phrase: "S."

Phrase: ","

Phrase: "Gallo,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.378: C., and Sarngadharan, M. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Sarngadharan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.380: (1992) Science 255, 1430-1432 [Medline] [OrderarticleviaInfotrieve] Miles, S. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1430-1432"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.381: A., Martinez-Maza, O., Rezai, A., Magpantay, L., Kishimoto, T., Nakamura, S., Radka, S. 

Phrase: "A.,"

Phrase: "Martinez-Maza,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Rezai,"

Phrase: "A.,"

Phrase: "Magpantay,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kishimoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "S."

Phrase: ","

Phrase: "Radka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.382: F., and Linsley, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Linsley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.383: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.384: (1992) Science 255, 1432-1434 [Medline] [OrderarticleviaInfotrieve] Bruce, A. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1432-1434"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.385: G., Hoggatt, I. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hoggatt,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.386: H., and Rose, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.387: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.389: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.390: 149, 1271-1275 [Abstract/Free FullText] Brown, T. 

Phrase: "149,"

Phrase: "1271-1275"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.391: J., Rowe, J. 

Phrase: "J.,"

Phrase: "Rowe,"

Phrase: "J."
Processing 00000000.tx.392: M., Liu, J. 

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "J."
Processing 00000000.tx.393: W., and Shoyab, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Shoyab,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.395: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.396: 147, 2175-2180 [Abstract/Free FullText] Richards, C. 

Phrase: "147,"

Phrase: "2175-2180"

Phrase: "[Abstract/Free FullText"

Phrase: "] Richards,"

Phrase: "C."
Processing 00000000.tx.397: D., Shoyab, M., Brown, T. 

Phrase: "D."

Phrase: ","

Phrase: "Shoyab,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.398: J., and Gauldie, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Gauldie,"

Phrase: "J."
Processing 00000000.tx.399: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.400: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.401: 150, 5596-5603 [Abstract/Free FullText] Richards, C. 

Phrase: "150,"

Phrase: "5596-5603"

Phrase: "[Abstract/Free FullText"

Phrase: "] Richards,"

Phrase: "C."
Processing 00000000.tx.402: D., Brown, T. 

Phrase: "D."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.403: J., Shoyab, M., Baumann, H., and Gauldie, J. 

Phrase: "J.,"

Phrase: "Shoyab,"

Phrase: "M."

Phrase: ","

Phrase: "Baumann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Gauldie,"

Phrase: "J."
Processing 00000000.tx.404: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.405: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.406: 148, 1731-1736 [Abstract/Free FullText] Rose, T. 

Phrase: "148,"

Phrase: "1731-1736"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.407: M., and Bruce, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.408: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.410: Natl. 

Phrase: "Natl."
Processing 00000000.tx.411: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.412: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.413: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.414: 88, 8641-8645 [Abstract] Bazan, J. 

Phrase: "88,"

Phrase: "8641-8645"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bazan,"

Phrase: "J."
Processing 00000000.tx.415: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.416: (1991) Neuron 7, 197-208 [Medline] [OrderarticleviaInfotrieve] Gearing, D. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuron 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "197-208"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.417: P., Ziegler, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ziegler,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.418: F., Comeau, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Comeau,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: R., Friend, D., Thoma, B., Cosman, D., Park, L., and Mosley, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Friend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "D."

Phrase: ","

Phrase: "Thoma,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cosman,"

Phrase: "D."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mosley,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.420: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.421: Natl. 

Phrase: "Natl."
Processing 00000000.tx.422: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.423: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.424: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.425: 91, 1119-1123 [Abstract] Stahl, N., Boulton, T. 

Phrase: "91,"

Phrase: "1119-1123"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stahl,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Boulton,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.426: G., Farruggella, T., Ip, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Farruggella,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ip,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.427: Y., Davis, S., Witthuhn, B. 

Phrase: "Y.,"

Phrase: "Davis,"

Phrase: "S."

Phrase: ","

Phrase: "Witthuhn,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.428: A., Quelle, F. 

Phrase: "A.,"

Phrase: "Quelle,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.429: W., Silvennoinen, O., Barbieri, G., Pellegrini, S., Ihle, J. 

Phrase: "W., Silvennoinen,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Barbieri,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pellegrini,"

Phrase: "S."

Phrase: ","

Phrase: "Ihle,"

Phrase: "J."
Processing 00000000.tx.430: N., and Yancopoulous, G. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Yancopoulous,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: D. 

Phrase: "D."
Processing 00000000.tx.432: (1994) Science 263, 92-95 [Medline] [OrderarticleviaInfotrieve] Schindler, C., and Darnell, J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 263,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "92-95"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schindler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Darnell,"

Phrase: "J."
Processing 00000000.tx.433: E., Jr. 

Phrase: "E.,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.434: (1995) Annu. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.435: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.436: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.437: 64, 621-651 [CrossRef][Medline] [OrderarticleviaInfotrieve] Bruder, J. 

Phrase: "64,"

Phrase: "621-651"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bruder,"

Phrase: "J."
Processing 00000000.tx.438: T., Heidecker, G., and Rapp, U. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Heidecker,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Rapp,"

Phrase: "U."
Processing 00000000.tx.439: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.440: (1992) Genes Dev. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.441: 6, 545-556 [Abstract] Deng, W. 

Phrase: "6,"

Phrase: "545-556"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.442: P., and Nickoloff, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Nickoloff,"

Phrase: "J."
Processing 00000000.tx.443: A. 

Phrase: "A."
Processing 00000000.tx.444: (1992) Anal. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.445: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.446: 200, 81-85 [Medline] [OrderarticleviaInfotrieve] Uchijima, M., Sato, H., Fujii, M., and Seiki, M. 

Phrase: "200,"

Phrase: "81-85"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Uchijima,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujii,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Seiki,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: 269, 14946-14050 [Abstract/Free FullText] Lim, K., and Chae, C. 

Phrase: "269,"

Phrase: "14946-14050"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Chae,"

Phrase: "C."
Processing 00000000.tx.451: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.452: (1989) Biotechniques 7, 576-579 [Medline] [OrderarticleviaInfotrieve] Chomczynski, P., and Sacchi, H. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biotechniques 7,"

Phrase: "576-579"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chomczynski,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Sacchi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.453: (1987) Anal. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.454: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.455: 162, 156 [CrossRef][Medline] [OrderarticleviaInfotrieve] Sambrook, J., Fritsch, E. 

Phrase: "162,"

Phrase: "156"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E."
Processing 00000000.tx.456: F., and Maniatis, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.457: (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY Fried, M., and Crothers, D. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual, 2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1825319:FRY [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Crothers,"

Phrase: "D."
Processing 00000000.tx.458: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.459: (1981) Nucleic Acids Res. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.460: 9, 6505-6525 [Abstract] Laemmli, U. 

Phrase: "9,"

Phrase: "6505-6525"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Laemmli,"

Phrase: "U."
Processing 00000000.tx.461: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.462: (1970) Nature 227, 680-685 [Medline] [OrderarticleviaInfotrieve] Hanemaaijer, R., Koolwijk, P., Le Clercq, L., De Vree, W. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Nature 227,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "680-685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hanemaaijer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koolwijk,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Le Clercq,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "De Vree,"

Phrase: "W."
Processing 00000000.tx.463: J.A., and Van Hinsbergh, V. 

Phrase: "J."

Phrase: "A.,"

Phrase: "and"

Phrase: "Van Hinsbergh,"

Phrase: "V."
Processing 00000000.tx.464: W.M. 

Phrase: "W.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.465: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.466: J. 

Phrase: "J."
Processing 00000000.tx.467: 296, 803-809 [Medline] [OrderarticleviaInfotrieve] Wagner, B. 

Phrase: "296,"

Phrase: "803-809"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wagner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.468: J., Hayes, T. 

Phrase: "J.,"

Phrase: "Hayes,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.469: I., Hoban, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hoban,"

Phrase: "C."
Processing 00000000.tx.470: J., and Cochran, B. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cochran,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.471: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.472: (1990) EMBO J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.473: 9, 4477-4484 [Abstract] Darnell, J. 

Phrase: "9,"

Phrase: "4477-4484"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Darnell,"

Phrase: "J."
Processing 00000000.tx.474: E., Jr., Kerr, I. 

Phrase: "E.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Kerr,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.475: M., and Stark, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stark, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.476: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: (1994) Science 264, 1415-1421 [Medline] [OrderarticleviaInfotrieve] Yuan, J., Wegenka, U. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1415-1421"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yuan,"

Phrase: "J.,"

Phrase: "Wegenka,"

Phrase: "U."
Processing 00000000.tx.478: M., Lutticken, C., Buschmann, J., Decker, T., Schindler, C., Heinrich, P. 

Phrase: "M."

Phrase: ","

Phrase: "Lutticken,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Buschmann,"

Phrase: "J.,"

Phrase: "Decker,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schindler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Heinrich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.479: C., and Horn, F. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Horn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019939:Horn [Body Part, Organ, or Organ Component]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.480: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.481: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.482: Biol. 

Phrase: "Biol."
Processing 00000000.tx.483: 14, 1657-1668 [Abstract] Lee, W., Mitchell, P., and Tjian, R. 

Phrase: "14,"

Phrase: "1657-1668"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lee,"

Phrase: "W.,"

Phrase: "Mitchell,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tjian,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: (1987) Cell 49, 741-752 [Medline] [OrderarticleviaInfotrieve] Zhong, Z., Wen, Z., and Darnell, J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Cell 49,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "741-752"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhong,"

Phrase: "Z.,"

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "Z.,"

Phrase: "and"

Phrase: "Darnell,"

Phrase: "J."
Processing 00000000.tx.485: E. 

Phrase: "E."
Processing 00000000.tx.486: (1994) Science 264, 95-98 [Medline] [OrderarticleviaInfotrieve] Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "95-98"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kamei,"

Phrase: "Y.,"

Phrase: "Xu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Heinzel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Torchia,"

Phrase: "J.,"

Phrase: "Kurokawa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gloss,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "S.-C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Heyman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: A., Rose, D. 

Phrase: "A.,"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.488: W., Glass, C. 

Phrase: "W., Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017596:Glass [Manufactured Object]
   861   C1947936:Glass [Medical Device]
   789 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   789 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.489: K., and Rosenfeld, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosenfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.490: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.491: (1996) Cell 85, 403-414 [Medline] [OrderarticleviaInfotrieve] Daum, G., Eisenmann-Tappe, I., Fries, H.-W., Troppmair, J., and Rapp, U. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 85,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "403-414"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Daum,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eisenmann-Tappe,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fries,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510451:Fries [Food]
  1000   C1825319:FRY [Gene or Genome]

Phrase: "H.-W., Troppmair,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Rapp,"

Phrase: "U."
Processing 00000000.tx.492: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: (1994) Trends Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.494: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.495: 19, 474-479 [CrossRef][Medline] [OrderarticleviaInfotrieve] Yu, C. 

Phrase: "19,"

Phrase: "474-479"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C."
Processing 00000000.tx.496: L., Meyer, D. 

Phrase: "L., Meyer,"

Phrase: "D."
Processing 00000000.tx.497: J., Campbell, G. 

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.498: S., Larner, A. 

Phrase: "S."

Phrase: ","

Phrase: "Larner,"

Phrase: "A."
Processing 00000000.tx.499: C., Carter-Su, C., Schwartz, J., and Jove, R. 

Phrase: "C., Carter-Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705534:SU [Idea or Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schwartz,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jove,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.500: (1995) Science 269, 81-83 [Medline] [OrderarticleviaInfotrieve] Dent, P., Jelinek, T., Morrison, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "81-83"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880278:DENT [Event]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jelinek,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Morrison,"

Phrase: "D."
Processing 00000000.tx.501: K., Weber, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.502: J., and Sturgill, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Sturgill,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.503: W. 

Phrase: "W."
Processing 00000000.tx.504: (1995) Science 268, 1902-1906 [Medline] [OrderarticleviaInfotrieve] Pope, A. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1902-1906"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044577:POPE [Lipid]

Phrase: "A."
Processing 00000000.tx.505: (1978) in Dynamic Properties of Glia Cells (Schoffeniels, E., Franck, G., Hertz, L., and Tower, D. B., eds), pp. 

Phrase: "(1978"

Phrase: ")"

Phrase: "in Dynamic Properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of Glia Cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   964   C0027836:Glial Cells [Cell]
           Glia
   861   C0007634:Cells [Cell]
   861   C1087003:Glia [Plant]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Schoffeniels,"

Phrase: "E.,"

Phrase: "Franck,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hertz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:hertz [Quantitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tower,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710443:Tower [Manufactured Object]

Phrase: "D. B.,"

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.506: 13-20, Pergamon, London Eddlestone, M., and Mucke, L. 

Phrase: "13-20,"

Phrase: "Pergamon,"

Phrase: "London Eddlestone,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.507: (1993) Neuroscience 54, 15-36 [CrossRef][Medline] [OrderarticleviaInfotrieve] Gottschall, P. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuroscience 54,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "15-36"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gottschall,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.508: E., and Xin, Y. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Xin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422556:XIN [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.509: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.511: 64, 1513-1520 [Medline] [OrderarticleviaInfotrieve] Price, D. 

Phrase: "64,"

Phrase: "1513-1520"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.512: L., Sisodia, S. 

Phrase: "L., Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.513: S., and Gandy, S. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: E. 

Phrase: "E."
Processing 00000000.tx.515: (1995) Curr. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.516: Opin. 

Phrase: "Opin."
Processing 00000000.tx.517: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.518: 8, 268-274 [Medline] [OrderarticleviaInfotrieve] Backstrom, J. 

Phrase: "8,"

Phrase: "268-274"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Backstrom,"

Phrase: "J."
Processing 00000000.tx.519: R., Miller, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.520: A., and Tokes, Z. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Tokes,"

Phrase: "Z."
Processing 00000000.tx.521: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.522: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.523: 58, 983-991 [Medline] [OrderarticleviaInfotrieve] Roberts, S. 

Phrase: "58,"

Phrase: "983-991"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: B., Ripellino, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ripellino,"

Phrase: "J."
Processing 00000000.tx.525: A., Ingalls, K. 

Phrase: "A.,"

Phrase: "Ingalls,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.526: M., Robakis, N. 

Phrase: "M."

Phrase: ","

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.527: K., and Felsenstein, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Felsenstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.528: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.529: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.530: Biol. 

Phrase: "Biol."
Processing 00000000.tx.531: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.532: 269, 3111-3116 [Abstract/Free FullText] Miyazaki, K., Hasegawa, M., Funahashi, K., and Umeda, M. 

Phrase: "269,"

Phrase: "3111-3116"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Funahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Umeda,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.534: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.535: 362, 839-841 Malik, N., Haugen, H. 

Phrase: "362,"

Phrase: "839-841 Malik,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Haugen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.536: S., Modrell, B., Shoyab, M., and Clegg, C. 

Phrase: "S."

Phrase: ","

Phrase: "Modrell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shoyab,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Clegg,"

Phrase: "C."
Processing 00000000.tx.537: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.538: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.539: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.540: Biol. 

Phrase: "Biol."
Processing 00000000.tx.541: 15, 2349-2358 [Abstract] Bugno, M., Graeve, L., Gatsios, P., Koj, A., Heinrich, P. 

Phrase: "15,"

Phrase: "2349-2358"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bugno,"

Phrase: "M."

Phrase: ","

Phrase: "Graeve,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gatsios,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koj,"

Phrase: "A.,"

Phrase: "Heinrich,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.542: C., Travis, J., and Kordula, T. 

Phrase: "C., Travis,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Kordula,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.543: (1995) Nucleic Acids Res. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.544: 23, 5041-5047 [Abstract] Benbrook, D. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "5041-5047"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Benbrook,"

Phrase: "D."
Processing 00000000.tx.545: M., and Jones, N. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.546: C. 

Phrase: "C."
Processing 00000000.tx.547: (1990) Oncogene 5, 295-302 [Medline] [OrderarticleviaInfotrieve] Ivashkiv, L. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Oncogene 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "295-302"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ivashkiv,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.548: B., Liou, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Liou,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.549: C., Kara, C. 

Phrase: "C., Kara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3591129:Kara [Eukaryote]

Phrase: "C."
Processing 00000000.tx.550: J., Lamph, W. 

Phrase: "J.,"

Phrase: "Lamph,"

Phrase: "W."
Processing 00000000.tx.551: W., Verma, I. 

Phrase: "W., Verma,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.552: M., and Glimcher, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Glimcher,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.553: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.554: (1990) Mol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.555: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: 10, 1609-1621 [Medline] [OrderarticleviaInfotrieve] Hai, T., and Curran, T. 

Phrase: "10,"

Phrase: "1609-1621"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Curran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.558: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.559: Natl. 

Phrase: "Natl."
Processing 00000000.tx.560: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.561: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.562: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.563: 88, 3720-3724 [Abstract] Avruch, J., Zhang, X., and Kyriakis, J. 

Phrase: "88,"

Phrase: "3720-3724"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Avruch,"

Phrase: "J.,"

Phrase: "Zhang,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Kyriakis,"

Phrase: "J."
Processing 00000000.tx.564: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.565: (1994) Trends Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.566: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.567: 19, 279-283 [CrossRef][Medline] [OrderarticleviaInfotrieve] Wen, Z., Zhong, Z., and Darnell, J. 

Phrase: "19,"

Phrase: "279-283"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "Z.,"

Phrase: "Zhong,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Darnell,"

Phrase: "J."
Processing 00000000.tx.568: E., Jr. 

Phrase: "E.,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.569: (1995) Cell 82, 241-250 [Medline] [OrderarticleviaInfotrieve] David, M., Petricon, E., III, Benjamin, C., Pine, R., Weber, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "241-250"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] David,"

Phrase: "M."

Phrase: ","

Phrase: "Petricon,"

Phrase: "E.,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "Benjamin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442989:Benjamin [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0872909:pine [Organic Chemical,Pharmacologic Substance]
  1000   C0885001:pine [Pharmacologic Substance]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.570: J., and Larner, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Larner,"

Phrase: "A."
Processing 00000000.tx.571: C. 

Phrase: "C."
Processing 00000000.tx.572: (1995) Science 269, 1721-1723 [Medline] [OrderarticleviaInfotrieve] Winston, L. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1721-1723"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Winston,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.573: A., and Hunter, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.574: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.575: Biol. 

Phrase: "Biol."
Processing 00000000.tx.576: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.577: 270, 30837-30840 [Abstract/Free FullText] Chrivia, J. 

Phrase: "270,"

Phrase: "30837-30840"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chrivia,"

Phrase: "J."
Processing 00000000.tx.578: C., Kwok, R. 

Phrase: "C., Kwok,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: P., Lamb, N., Hagiwara, M., Montminy, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hagiwara,"

Phrase: "M."

Phrase: ","

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.580: R., and Goodman, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goodman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.581: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.582: (1993) Nature 365, 855-859 [CrossRef][Medline] [OrderarticleviaInfotrieve] Kwok, R. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 365,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "855-859"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kwok,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.583: P., Lundblad, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lundblad,"

Phrase: "J."
Processing 00000000.tx.584: R., Chrivia, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chrivia,"

Phrase: "J."
Processing 00000000.tx.585: C., Richards, J. 

Phrase: "C., Richards,"

Phrase: "J."
Processing 00000000.tx.586: P., Bachinger, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bachinger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.587: P., Brennan, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brennan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.588: G., Roberts, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.589: G., Green, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.590: R., and Goodman, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goodman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.591: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.592: (1994) Nature 370, 223-226 [CrossRef][Medline] [OrderarticleviaInfotrieve] Arias, J., Alberts, A. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 370,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "223-226"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Arias,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006301:Aria [Plant]

Phrase: "J.,"

Phrase: "Alberts,"

Phrase: "A."
Processing 00000000.tx.593: S., Brindle, P., Claret, F. 

Phrase: "S."

Phrase: ","

Phrase: "Brindle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Claret,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.594: X., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. 

Phrase: "X.,"

Phrase: "Smeal,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Karin,"

Phrase: "M."

Phrase: ","

Phrase: "Feramisco,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.595: (1994) Nature 370, 226-229 [CrossRef][Medline] [OrderarticleviaInfotrieve] Liu, J., Clegg, C. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 370,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "226-229"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liu,"

Phrase: "J.,"

Phrase: "Clegg,"

Phrase: "C."
Processing 00000000.tx.596: H., and Shoyab, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Shoyab,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: (1992) Cell Growth Diff. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cell Growth Diff."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007595:Cell Growth [Cell Function]
Processing 00000000.tx.598: 3, 307-313 [Abstract] Gearing, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "307-313"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.599: P., and Bruce, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Bruce,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332417:BRUCE [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.600: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.601: (1992) Nat. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.602: New Biol. 

Phrase: "New Biol."
Processing 00000000.tx.603: 4, 61-65 Thoma, B., Bird, T. 

Phrase: "4,"

Phrase: "61-65 Thoma,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.604: A., Friend, D. 

Phrase: "A.,"

Phrase: "Friend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "D."
Processing 00000000.tx.605: J., Gearing, D. 

Phrase: "J.,"

Phrase: "Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.606: P., and Dower, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dower,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.607: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.608: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.609: Biol. 

Phrase: "Biol."
Processing 00000000.tx.610: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.611: 269, 6215-6222 [Abstract/Free FullText] Apodaca, G., Rutka, J. 

Phrase: "269,"

Phrase: "6215-6222"

Phrase: "[Abstract/Free FullText"

Phrase: "] Apodaca,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rutka,"

Phrase: "J."
Processing 00000000.tx.612: T., Bouhana, K., Berens, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bouhana,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Berens,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.613: E., Giblin, J. 

Phrase: "E.,"

Phrase: "Giblin,"

Phrase: "J."
Processing 00000000.tx.614: E., Rosenblum, M. 

Phrase: "E.,"

Phrase: "Rosenblum,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.615: L., McKerrow, J. 

Phrase: "L., McKerrow,"

Phrase: "J."
Processing 00000000.tx.616: H., and Banda, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Banda,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.617: J. 

Phrase: "J."
Processing 00000000.tx.618: (1990) Cancer Res. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.619: 50, 2322-2329 [Abstract] Ausubel, F. 

Phrase: "50,"

Phrase: "2322-2329"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ausubel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.620: M., Brent, R., Kingston, R. 

Phrase: "M."

Phrase: ","

Phrase: "Brent,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kingston,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.621: E., Moore, D. 

Phrase: "E.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.622: D., Seidman, J. 

Phrase: "D."

Phrase: ","

Phrase: "Seidman,"

Phrase: "J."
Processing 00000000.tx.623: C., Smith, J. 

Phrase: "C., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.624: A., and Struhl, K. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Struhl,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.625: (1995) Current Protocols in Molecular Biology, John Wiley &Sons, Inc., New York 1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(1995"

Phrase: ")"

Phrase: "Current Protocols in Molecular Biology,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0442711:Protocols [Intellectual Product]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "John Wiley &Sons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "Inc.,"

Phrase: "New York 1997 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0027976:New York [Geographic Area]
   748   C0037455:society [Organization]
   748   C0205314:New [Temporal Concept]
   748   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

